Disorder of lipoprotein metabolism, unspecified

E4_LIPOPROTNAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.8, E78.8+M14.3, E78.9 Hospital discharge: ICD-9 — 272[7-9] Hospital discharge: ICD-8 — 27288\|2729 Cause of death: ICD-10 — E78.8, E78.8+M14.3, E78.9 Cause of death: ICD-9 — 272[7-9] Cause of death: ICD-8 — 27288\|2729 2 out of 7 registries used, show all original rules.	5644
4. Check minimum number of events None	5644
5. Include endpoints None	5644
6. Filter based on genotype QC (FinnGen only)	5644

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_LIPOPROTNAS
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E78[8-9]
HD_ICD_9	272[7-9]
HD_ICD_8	27288\|2729
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E78[8-9]
COD_ICD_9	272[7-9]
COD_ICD_8	27288\|2729
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorder of lipoprotein metabolism, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35890	16241	19519
Only index persons	34064	15569	18495
Unadjusted period prevalence (%)
Whole population	0.51	0.47	0.55
Only index persons	0.64	0.57	0.71
Median age at first event (years)
Whole population	67.40	70.76	64.61
Only index persons	67.34	70.61	64.60

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5644	2326	3318
Unadjusted period prevalence (%)	1.19	0.79	1.46
Median age at first event (years)	65.37	65.96	64.96

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5098: Matched controls
50978

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I10

ICD-10 Finland

Essential (primary) hypertension

4.5

323.0

4106

24487

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

4.7

323.0

2206

7131

C10AX09

ATC

ezetimibe; oral

5.5

323.0

1129

2486

C07AB07

ATC

bisoprolol; oral

3.2

323.0

3337

18800

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.5

323.0

2253

7571

C10AA05

ATC

atorvastatin; oral

4.7

323.0

3247

13799

C10AA01

ATC

simvastatin; oral

6.2

323.0

3866

17173

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

19.0

323.0

1038

677

B01AC04

ATC

clopidogrel; oral

4.5

323.0

1571

4595

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

57.3

323.0

576

113

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

9.9

323.0

1815

2707

AN1

Coronary angiography

5.1

323.0

1340

3315

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

4.7

323.0

1986

6147

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.8

323.0

2114

8075

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

11427.6

323.0

4911

162

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.5

314.6

1935

7563

C01DA14

ATC

isosorbide mononitrate; oral

3.9

310.0

1541

5039

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.9

304.8

1153

2893

C10AA07

ATC

rosuvastatin; oral

3.4

296.2

1866

7354

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.5

279.7

914

1931

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.6

270.9

1546

5565

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.2

267.7

1870

7826

103

Kela drug reimbursment

Diabetes, insulin-treated

3.1

266.0

2060

9252

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.2

262.5

916

2075

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

232.7

1891

8580

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.0

227.9

1706

7313

A10BA02

ATC

metformin; oral

2.8

224.9

2032

9805

I25.2

ICD-10 Finland

Old myocardial infarction

5.1

223.7

780

1743

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

206.2

2771

16487

A10AE04

ATC

insulin glargine; parenteral

4.3

198.1

832

2230

C03CA01

ATC

furosemide; systemic

2.6

198.0

2132

11167

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

5.4

196.8

644

1329

C08CA01

ATC

amlodipine; oral

2.5

192.4

2432

13820

C09AA05

ATC

ramipril; oral

2.6

192.0

1852

9077

T90

ICPC

Diabetes non-insulin dependent

2.7

191.5

1666

7681

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

3.0

178.2

1267

5103

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.7

164.3

801

2423

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.5

163.5

640

1584

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.8

162.9

492

914

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.6

162.0

445

731

205

Kela drug reimbursment

Chronic hypertension

2.4

161.0

2024

11150

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.2

159.3

536

1130

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.9

158.2

1170

4785

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

156.3

1481

7011

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

5.0

156.2

546

1199

I20.09

ICD-10 Finland

Unstable angina

4.7

151.4

562

1314

C10AA04

ATC

fluvastatin; oral

3.5

147.5

764

2412

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.4

145.4

569

1400

Angiography of the heart and coronary arteries

3.9

141.0

637

1789

E78.8

ICD-10 Finland

Other disorders of lipoprotein metabolism

168.1

140.2

147

XF402

NOMESCO Finland

ECG with work load test

3.2

138.9

833

2929

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

138.4

1093

4605

I20.99

ICD-10 Finland

Angina pectoris, unspecified

4.0

138.4

614

1696

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

5.4

136.4

441

883

E66.00

ICD-10 Finland

Metabolic syndrome

5.2

133.0

445

926

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

7.5

132.1

327

460

A10AE05

ATC

insulin detemir; parenteral

4.8

131.9

475

1070

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.8

131.2

609

1746

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.8

123.7

444

995

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

17.6

123.0

197

116

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.4

121.0

480

1189

R06.0

ICD-10 Finland

Dyspnoea

2.2

118.5

1495

7970

G47.3

ICD-10 Finland

Sleep apnoea

2.4

118.5

1273

6282

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

118.1

1127

5229

I25

ICD-10 Finland

Chronic ischaemic heart disease

4.3

117.7

477

1205

A02BC02

ATC

pantoprazole; systemic

2.0

117.6

3405

25469

N02BE01

ATC

paracetamol; systemic, rectal

2.4

113.0

4394

36881

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

112.4

1013

4543

E66.8

ICD-10 Finland

Other obesity

5.6

109.9

340

643

SPAT1262

SPAT

Handing over of treatment supplies

2.3

109.2

1183

5827

AN4

Balloon angioplasty and drug eluding stent

5.5

108.6

343

664

AN3

Balloon angioplasty and metallic stent

5.7

107.5

326

601

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

5.9

106.1

315

566

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.4

106.0

416

1016

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

103.4

1037

4894

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

9.1

99.5

217

248

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.6

99.5

365

832

C07AB02

ATC

metoprolol; systemic

2.1

99.5

1364

7443

E66.01

ICD-10 Finland

Obesity due to excess calories

4.1

99.4

413

1063

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

97.8

1710

10295

A10BH01

ATC

sitagliptin; oral

2.9

97.4

683

2621

I20.01

ICD-10 Finland

Unstable angina

5.2

96.4

317

642

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.6

95.8

473

1412

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

95.2

1619

9618

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

94.3

684

2678

R4110

NOMESCO Finland

Physiotherapy

2.0

94.3

1474

8461

C10AA03

ATC

pravastatin; oral

3.2

91.3

533

1804

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.7

90.8

433

1254

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.6

89.8

332

761

AA1AD

NOMESCO Finland

CT of head and brain

2.0

89.8

1381

7844

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

8.6

89.1

201

243

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

4.9

88.5

308

663

T89

ICPC

Diabetes insulin dependent

5.5

88.0

273

516

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.6

87.4

700

2897

B01AA03

ATC

warfarin; systemic

2.0

86.0

1369

7861

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

85.9

451

1409

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.9

85.3

380

1038

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

84.6

1525

9174

C08CA13

ATC

lercanidipine; oral

2.3

82.8

855

4048

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

6.0

82.1

237

410

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.4

81.4

430

1348

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.8

79.7

238

429

E66.9

ICD-10 Finland

Obesity, unspecified

5.8

79.7

236

421

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

78.5

683

2952

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

77.8

1134

6241

E86

ICD-10 Finland

Volume depletion

31.2

77.7

104

J01DB01

ATC

cefalexin; oral

1.9

77.3

3947

33019

C10AA02

ATC

lovastatin; oral

3.7

77.2

368

1062

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.9

77.2

517

1911

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.0

76.1

480

1704

C02AC05

ATC

moxonidine; oral

3.6

74.6

360

1049

C03DA01

ATC

spironolactone; oral

2.4

74.5

700

3144

L28

ICPC

Limited function/disability (L)

2.1

73.8

941

4882

N02AX02

ATC

tramadol; systemic, rectal

1.7

73.5

2219

15667

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

31.2

73.3

N03AX16

ATC

pregabalin; oral

2.0

73.2

1234

7166

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.8

73.0

256

554

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.5

72.1

267

612

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

71.5

472

1725

I20.90

ICD-10 Finland

Angina pectoris, unspecified

4.0

70.1

301

793

A10BB12

ATC

glimepiride; oral

2.7

69.9

534

2134

I50.0

ICD-10 Finland

Congestive heart failure

2.7

69.6

536

2153

A10BK03

ATC

empagliflozin; oral

2.9

68.4

447

1622

E87.6

ICD-10 Finland

Hypokalaemia

10.0

67.4

138

141

M79.6

ICD-10 Finland

Pain in limb

1.8

66.9

1705

11332

AA1

Conventional CABG

5.6

66.8

203

374

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

66.4

2197

15774

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

66.4

571

2435

I20.00

ICD-10 Finland

Unstable angina

4.1

66.4

271

682

C03AA03

ATC

hydrochlorothiazide; oral

2.4

66.3

636

2877

A10AA01

ATC

5.9

66.2

194

342

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

65.1

887

4708

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

64.9

754

3731

C09CA01

ATC

losartan; oral

1.8

64.0

1344

8370

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.9

63.9

425

1556

A10BJ06

ATC

semaglutide; parenteral

4.8

63.5

224

488

WX722

NOMESCO Finland

PEEP

3.3

63.4

343

1090

R42

ICD-10 Finland

Dizziness and giddiness

1.9

63.2

1162

6907

C10AB05

ATC

fenofibrate; oral

6.4

63.1

172

276

160

Kela drug reimbursment

exenatide

6.2

62.9

177

296

E87.5

ICD-10 Finland

Hyperkalaemia

18.6

61.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

60.9

1580

10485

B01AC24

ATC

ticagrelor; oral

4.1

60.8

252

643

M04AA01

ATC

allopurinol; systemic

2.1

60.4

822

4348

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

59.3

745

3809

A10AA02

ATC

4.2

59.2

239

595

A10BJ02

ATC

liraglutide; parenteral

5.5

56.8

176

332

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.7

55.8

198

434

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

10.5

55.7

111

108

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.8

55.7

251

689

B04AB02

ATC

4.9

54.9

186

388

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

54.5

477

2046

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

13.2

53.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

53.9

520

2346

207

Kela drug reimbursment

Chronic arrhythmias

1.9

53.2

918

5293

XF404

NOMESCO Finland

Ambulatory ECG

2.3

52.9

543

2521

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.6

52.9

423

1727

177

Kela drug reimbursment

Insulin glargine 300 U / ml

5.9

52.8

153

266

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.2

52.5

289

929

280

Kela drug reimbursment

Clopidogrel

6.0

52.4

150

257

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

52.3

690

3584

A10BH05

ATC

linagliptin; oral

2.9

52.2

333

1185

AP1

Catheterization of the left side of the heart

5.3

51.7

163

314

R07.3

ICD-10 Finland

Other chest pain

2.3

51.6

512

2338

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.1

51.4

211

533

H04AA01

ATC

glucagon; nasal, parenteral

6.8

51.4

133

199

R53

ICD-10 Finland

Malaise and fatigue

1.8

51.4

961

5691

R03AC02

ATC

salbutamol; inhalant

1.6

51.2

2299

17474

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.2

51.2

164

322

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

50.9

565

2721

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.5

50.7

251

744

M10.9

ICD-10 Finland

Gout, unspecified

2.5

50.6

431

1820

C09AA02

ATC

enalapril; systemic

1.7

50.3

1164

7376

J01FF01

ATC

clindamycin; systemic

1.7

50.2

1287

8414

J01MA12

ATC

levofloxacin; systemic

1.8

49.7

1017

6195

SPAT1325

SPAT

Vaccination

1.6

49.6

1849

13378

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

18.2

49.3

A10AE06

ATC

insulin degludec; parenteral

4.7

49.1

172

372

ZYC01

SPAT

3.1

49.1

289

974

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

48.9

1646

11585

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

6.4

48.8

132

210

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

48.7

356

1376

Single vessel balloon catheter extension

4.1

48.6

198

497

H3603, E103

ICD-10 Finland

12.1

48.1

H02AB06

ATC

prednisolone; systemic

1.6

47.8

2246

17151

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.4

47.4

432

1886

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.1

47.1

281

955

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.7

46.8

341

1315

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

46.2

891

5309

B01AB05

ATC

enoxaparin; parenteral

1.6

46.0

1520

10611

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

45.9

1283

8560

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.5

45.0

166

379

AN2

Balloon angioplasty, including several vessels

3.5

44.9

219

642

TFP20

NOMESCO Finland

Cardiodefibrillation

2.2

44.7

484

2299

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

44.5

1477

10301

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

44.5

1274

8542

OAB42

SPAT

3.0

43.7

262

892

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.6

43.6

206

588

C10AB02

ATC

bezafibrate; oral

6.2

43.6

121

200

A46

ICD-10 Finland

Erysipelas

1.9

43.2

768

4441

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

42.8

312

1204

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.1

42.3

250

844

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

42.1

551

2839

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.4

42.0

158

368

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.7

41.7

190

527

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.0

41.4

118

202

E10

ICD-10 Finland

Type 1 diabetes mellitus

6.1

41.3

115

191

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

41.1

412

1884

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

41.0

828

4991

A02BC05

ATC

esomeprazole; systemic

1.5

40.7

1859

13938

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

40.3

769

4547

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

39.9

1824

13658

C01BD01

ATC

amiodarone; systemic

3.3

39.3

212

671

E78.49

ICD-10 Finland

Other hyperlipidaemia

12.2

39.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

39.1

1463

10439

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

39.0

236

809

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.3

38.9

148

349

ZX120

NOMESCO Finland

Intravenous

2.1

38.8

484

2438

I20.91

ICD-10 Finland

Angina pectoris, unspecified

5.1

38.5

126

254

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.6

38.4

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

38.4

556

2975

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

38.3

592

3248

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

38.3

173

477

A10BX07

ATC

[U] liraglutide; parenteral

6.1

37.8

105

174

C07AG02

ATC

carvedilol; oral

2.3

37.8

372

1684

WX110

NOMESCO Finland

Local anesthesy

1.5

37.8

2947

24608

A11CC03

ATC

alfacalcidol; systemic

4.3

37.7

143

336

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

4.0

37.6

156

399

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

4.5

37.4

137

311

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

37.4

354

1573

R2110

NOMESCO Finland

Giving the first information

2.5

37.3

315

1320

WZC30

NOMESCO Finland

Teaching

1.8

37.2

668

3861

R11

ICD-10 Finland

Nausea and vomiting

2.3

37.2

358

1603

J01DA01

ATC

[U] cefalexin; systemic

1.5

37.0

2842

23600

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

13.8

37.0

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

15.4

36.9

WX892

NOMESCO Finland

Monitored bed care

2.2

36.9

399

1890

C09CA03

ATC

valsartan; oral

2.0

36.7

500

2612

M54.5

ICD-10 Finland

Low back pain

1.6

36.6

1370

9745

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.3

36.5

139

328

H3600, E103

ICD-10 Finland

9.9

36.4

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

9.4

36.3

XF640

NOMESCO Finland

3.2

36.2

203

661

I50

ICD-10 Finland

Heart failure

3.0

36.1

220

758

I50.1

ICD-10 Finland

Left ventricular failure

2.5

35.9

308

1301

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

14.3

35.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

35.8

858

5428

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.9

35.6

151

394

B01AF02

ATC

apixaban; oral

1.9

35.4

569

3158

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.0

35.4

145

367

SPAT1336

SPAT

Request for examination

3.0

35.4

216

746

J01CA04

ATC

amoxicillin; systemic

1.5

35.4

3557

31052

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

35.2

805

5018

UJF32

NOMESCO Finland

Coloscopy

1.6

35.0

1271

8958

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

35.0

426

2121

SPAT1254

SPAT

Administration of medicine

1.8

34.9

717

4323

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

34.7

224

802

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

34.7

655

3842

H3601, E103

ICD-10 Finland

9.7

34.6

162

Kela drug reimbursment

liraglutide

6.2

34.2

154

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

34.1

655

3862

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

34.0

247

951

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

33.9

1408

10224

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.9

33.8

218

780

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

33.7

367

1739

WW200

SPAT

2.0

33.7

459

2396

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.8

33.6

115

244

B01AC07

ATC

dipyridamole; systemic

2.4

33.6

304

1318

N06AX11

ATC

mirtazapine; oral

1.5

33.5

1349

9725

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

6.8

33.3

126

Coronary artery bypass surgery

3.3

33.3

172

528

A10BK01

ATC

dapagliflozin; oral

2.7

33.2

242

932

RD210

NOMESCO Finland

5.1

33.2

108

217

WX872

NOMESCO Finland

Intensive care

2.5

33.2

276

1146

E66.0

ICD-10 Finland

Obesity due to excess calories

6.3

33.2

145

J01MA02

ATC

ciprofloxacin; systemic

1.5

33.2

1875

14523

M48.0

ICD-10 Finland

Spinal stenosis

1.8

33.0

654

3893

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

5.3

32.9

103

198

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

16.2

32.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

32.3

718

4426

R55

ICD-10 Finland

Syncope and collapse

1.8

32.1

555

3159

A10BD07

ATC

metformin and sitagliptin; systemic

2.6

32.0

249

997

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

31.8

497

2730

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

9.0

31.5

A10BG03

ATC

pioglitazone; oral

3.3

31.5

166

518

L17

ICPC

Foot/toe symptom/complaint

1.5

31.5

1140

7999

A02BC01

ATC

omeprazole; systemic

1.5

31.3

1301

9414

C09BA02

ATC

enalapril and diuretics; systemic

1.9

31.3

491

2696

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

10.3

31.3

N06AX21

ATC

duloxetine; oral

2.0

31.2

423

2199

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

31.1

210

773

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

31.0

1095

7632

TK800

NOMESCO Finland

Hemodialysis

3.8

31.0

136

367

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

30.9

879

5802

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.2

30.9

119

285

K78

ICPC

Atrial fibrillation/flutter

1.9

30.7

473

2582

H03AA01

ATC

levothyroxine sodium; systemic

1.6

30.7

947

6383

ZXA00

NOMESCO Finland

Right side

1.5

30.5

1329

9709

SPAT1263

SPAT

Sampling

1.4

30.3

1884

14798

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

30.2

1534

11572

C08CA02

ATC

felodipine; oral

1.8

30.2

533

3051

C09DA01

ATC

losartan and diuretics; oral

1.8

30.2

549

3177

J01AA02

ATC

doxycycline; systemic

1.4

30.1

3635

32244

C08DB01

ATC

diltiazem; oral

2.2

30.1

333

1591

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.1

30.1

121

302

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

30.1

548

3171

V03AE01

ATC

polystyrene sulfonate; oral

5.5

30.1

169

111

Conventional CABG

6.5

30.0

123

N19

ICD-10 Finland

Unspecified kidney failure

2.9

29.9

194

697

R51.80

ICD-10 Finland

Headache

1.8

29.9

536

3083

E66

ICD-10 Finland

Obesity

3.1

29.8

171

566

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

29.7

1101

7753

S97

ICPC

Chronic ulcer skin

2.3

29.6

300

1377

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

29.6

790

5124

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.5

29.5

107

242

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

29.4

533

3077

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.1

29.3

117

290

ZXA05

NOMESCO Finland

Left side

1.5

29.2

1248

9066

WZC00

SPAT

2.8

29.2

200

745

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

7.8

28.8

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.4

28.7

106

244

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

28.7

670

4181

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.4

28.6

144

435

H3603, E113

ICD-10 Finland

5.8

28.6

143

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

28.4

306

1444

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

28.4

579

3470

A02BC03

ATC

lansoprazole; oral

1.5

28.3

1351

10035

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

28.3

860

5762

A10BX04

ATC

[U] exenatide; parenteral

5.8

28.3

141

ZXA10

NOMESCO Finland

Bilateral

1.6

28.2

907

6163

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

4.4

28.1

103

236

EB1AA

SPAT

2.6

28.0

208

812

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

4.5

28.0

102

232

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

27.7

290

1351

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.7

27.7

202

780

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

27.3

473

2685

K02

ICD-10 Finland

Dental caries

2.1

27.3

310

1495

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

27.3

556

3331

WX002

NOMESCO Finland

Sedation and analgesia

1.6

27.2

929

6395

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.9

27.2

114

296

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.7

27.2

140

M25.5

ICD-10 Finland

Pain in joint

1.5

27.2

1095

7833

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.0

27.1

163

558

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.6

27.0

107

C09CA06

ATC

candesartan; oral

1.5

26.9

950

6596

A10BX01

ATC

guar gum; systemic

2.5

26.6

222

925

R4120

NOMESCO Finland

Occupational therapy

2.2

26.5

286

1350

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.5

26.5

SPAT1285

SPAT

Provision of consultation response

2.2

26.5

279

1304

R02

ICPC

Shortness of breath/dyspnoea

1.7

26.4

563

3414

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.3

26.4

247

1090

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

26.4

215

884

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

26.4

443

2489

I20.0

ICD-10 Finland

Unstable angina

5.8

26.3

130

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

5.7

26.3

134

2729X

ICD-9 Finland

Disorders of lipoid metabolism, Unspecified disorder of lipoid metabolism

+∞

26.1

J01FA06

ATC

roxithromycin; oral

1.4

26.0

1737

13711

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

4.7

26.0

195

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

8.7

25.9

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

25.9

650

4135

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.8

25.8

111

295

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.6

25.8

117

326

N02AA05

ATC

oxycodone; systemic

1.6

25.5

729

4800

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

25.3

338

1746

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

25.3

858

5890

N03AX12

ATC

gabapentin; oral

1.6

25.3

664

4272

EBA00

NOMESCO Finland

Extraction of tooth

1.4

25.3

1342

10135

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.7

25.0

185

Z71.8

ICD-10 Finland

Other specified counselling

1.5

24.9

913

6376

R05

ICD-10 Finland

Cough

1.5

24.8

837

5735

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

24.7

153

533

H3601, E113

ICD-10 Finland

3.7

24.5

110

304

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.3

24.5

126

388

XG466

NOMESCO Finland

Sleep oxymetry

2.7

24.3

173

659

M54

ICD-10 Finland

Dorsalgia

1.8

24.3

440

2535

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

24.1

298

1491

I20

ICD-10 Finland

Angina pectoris

3.7

24.0

107

294

T82

ICPC

Obesity

3.0

24.0

139

466

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

23.9

393

2188

SPAT1229

SPAT

Assessment of need for aid

1.8

23.9

408

2304

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

23.9

1870

15108

WX110

SPAT

2.5

23.9

186

747

C07AB05

ATC

betaxolol; oral

2.6

23.9

175

679

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

23.8

350

1875

A10AB06

ATC

insulin glulisine; parenteral

5.4

23.8

135

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.3

23.7

123

381

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.1

23.7

264

1265

CKC12

NOMESCO Finland

Photocoagulation of retina

2.3

23.7

217

947

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

23.5

434

2515

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

23.4

271

1320

WX882

NOMESCO Finland

High dependency care

2.9

23.3

145

507

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

7.5

23.3

A28

ICPC

Limited function/disability NOS

1.6

23.2

741

5004

C08CA05

ATC

nifedipine; systemic

1.9

23.0

338

1810

N06AA09

ATC

amitriptyline; systemic

1.8

23.0

446

2624

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

8.8

23.0

C07AB08

ATC

celiprolol; oral

2.6

22.9

172

675

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.0

22.7

305

1577

C10AB04

ATC

gemfibrozil; oral

5.0

22.7

151

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

6.1

22.6

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

22.6

2029

16722

T31

ICPC

Metabolic, Medical examin/health eval partial

5.8

22.6

111

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.3

22.5

210

926

A12BA01

ATC

potassium chloride; oral

2.1

22.5

255

1229

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.2

22.4

240

1128

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

22.4

2872

25000

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

22.4

325

1733

315

Kela drug reimbursment

Clopidogrel

4.4

22.4

189

M01AE02

ATC

naproxen; oral, rectal

1.3

22.2

2327

19633

J20

ICD-10 Finland

Acute bronchitis

1.8

22.1

405

2339

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

11.5

22.1

N18.0

ICD-10 Finland

End-stage renal disease

4.6

22.1

173

A02BA02

ATC

ranitidine; systemic

1.5

22.1

937

6734

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

6.3

22.1

T45

ICPC

Metabolic, Observ/health educat/advice/diet

3.5

22.0

103

295

A11

ICPC

Chest pain NOS

1.9

22.0

343

1874

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.0

2143

17862

R60.0

ICD-10 Finland

Localized oedema

1.7

22.0

522

3260

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

21.9

731

4981

T66

ICPC

Metabolic, Referral to non-MD provider

11.8

21.9

NHQ40

NOMESCO Finland

Amputation of toe

3.4

21.9

108

323

C09DA03

ATC

valsartan and diuretics; oral

2.1

21.9

262

1295

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

21.9

474

2884

N05BA04

ATC

oxazepam; oral

1.5

21.8

1004

7342

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.7

21.8

257

K30

ICD-10 Finland

Functional dyspepsia

1.8

21.7

414

2422

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

21.7

957

6933

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

21.7

622

4088

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

21.6

1046

7721

H36.01

ICD-10 Finland

Diabetic maculopathy

4.5

21.6

173

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

21.6

701

4747

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.9

21.4

226

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

21.4

206

924

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.9

21.4

236

M10

ICD-10 Finland

Gout

2.1

21.3

242

1168

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.6

21.3

111

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

21.3

1621

12970

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

21.3

213

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.7

21.2

146

545

E87.2

ICD-10 Finland

Acidosis

+∞

20.8

M01AB05

ATC

diclofenac; systemic, rectal

1.3

20.8

2883

25253

E78.11

ICD-10 Finland

Other hypertriglyceridemia

14.1

20.8

A10BB01

ATC

glibenclamide; oral

2.1

20.7

244

1195

C10AX13

ATC

evolocumab; parenteral

30.1

20.5

ZXH06

SPAT

2.8

20.5

134

487

F43

ICPC

Eye, Other diagnostic procedure

3.3

20.5

105

324

R05FB02

ATC

cough suppressants and expectorants

1.4

20.4

1692

13705

N06AB10

ATC

escitalopram; oral

1.6

20.3

638

4283

S18

ICPC

Laceration/cut

1.3

20.2

1934

16008

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

20.2

1614

12992

N30

ICD-10 Finland

Cystitis

2.0

20.2

279

1461

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

20.0

343

1938

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

19.9

179

777

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.3

19.9

179

777

K90

ICPC

Stroke/cerebrovascular accident

2.6

19.9

147

575

A04

ICPC

Weakness/tiredness general

1.6

19.9

535

3453

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.6

19.8

152

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.7

19.8

238

M03BX02

ATC

tizanidine; oral

1.3

19.8

2464

21183

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.0

19.7

117

400

CK2S4

SPAT

5.9

19.7

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

19.7

2040

17066

WW200

NOMESCO Finland

Immunization

2.8

19.7

130

476

T69

ICPC

Metabolic, Other reason for encounter NEC

6.3

19.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

19.5

330

1854

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.6

19.5

149

594

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

19.5

360

2084

XF602

NOMESCO Finland

Bloodpressure monitoring

4.6

19.4

146

A98

ICPC

Health maint/preventive medicine

1.5

19.4

4479

42297

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

19.4

173

749

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.5

19.4

154

627

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.7

19.3

131

486

H3600, E113

ICD-10 Finland

3.7

19.3

238

C09AA04

ATC

perindopril; oral

1.9

19.2

273

1442

A12AA04

ATC

calcium carbonate; oral

3.8

19.2

219

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

19.2

1066

8052

C09DA06

ATC

candesartan and diuretics; oral

1.8

19.0

352

2039

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.5

18.9

252

R06.2

ICD-10 Finland

Wheezing

2.2

18.9

188

856

T60

ICPC

Metabolic, Result test/procedure

4.7

18.9

137

N25.0

ICD-10 Finland

Renal osteodystrophy

14.8

18.9

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.5

18.8

248

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

15.9

18.8

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.2

18.7

202

956

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.8

18.7

130

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

7.4

18.6

TQW40

SPAT

2.4

18.6

161

685

T62

ICPC

Metabolic, Administrative procedure

8.6

18.6

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

4.6

18.5

140

B04AB01

ATC

3.5

18.5

247

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

18.4

271

1450

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.1

18.4

173

N06AB04

ATC

citalopram; systemic

1.5

18.4

833

6048

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.7

18.4

127

479

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

18.2

130

499

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.1

18.2

104

345

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

18.2

296

1643

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

18.1

225

1127

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

18.1

1030

7798

FXZ00

NOMESCO Finland

Off-pump cardiac operation

5.8

18.1

S20

ICPC

Corn/callosity

2.9

18.0

112

396

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

18.0

350

2060

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.2

18.0

301

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

10.7

17.9

I49.5

ICD-10 Finland

Sick sinus syndrome

2.1

17.8

207

1011

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

17.8

655

4553

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

7.6

17.8

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.1

17.8

100

331

A10BG02

ATC

rosiglitazone; oral

3.3

17.8

271

G44.2

ICD-10 Finland

Tension-type headache

1.6

17.7

445

2815

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

3.1

17.7

101

335

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

17.7

413

2566

AA2

Off pump CABG sternotomy

6.8

17.7

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.6

2738

24093

N06AX16

ATC

venlafaxine; oral

1.6

17.6

425

2665

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

7.5

17.6

R03BB04

ATC

tiotropium bromide; inhalant

1.6

17.6

488

3173

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

7.2

17.5

R52.9

ICD-10 Finland

Pain, unspecified

1.8

17.5

337

1978

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

15.6

17.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

17.3

558

3759

C01AA05

ATC

digoxin; systemic

1.6

17.3

439

2787

L60.0

ICD-10 Finland

Ingrowing nail

2.2

17.3

182

852

ACC51

NOMESCO Finland

Release of median nerve

1.8

17.2

290

1629

358

Kela drug reimbursment

liraglutide

6.8

17.2

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

17.1

289

1622

Z50.1

ICD-10 Finland

Other physical therapy

1.9

17.1

243

1286

T30

ICPC

Metabolic, Medical examin/health eval complete

9.3

17.1

M10.0

ICD-10 Finland

Idiopathic gout

2.2

17.1

175

808

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

17.0

139

575

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

17.0

167

756

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.0

17.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

16.9

722

5173

M65.3

ICD-10 Finland

Trigger finger

2.2

16.9

179

842

R07.2

ICD-10 Finland

Precordial pain

2.9

16.8

103

361

R50.9

ICD-10 Finland

Fever, unspecified

1.5

16.8

571

3898

B04AC02

ATC

6.7

16.7

R31

ICD-10 Finland

Unspecified haematuria

1.6

16.7

509

3383

SPAT1310

SPAT

Counselling related to known health issue

1.3

16.7

1355

10861

N05CF01

ATC

zopiclone; oral

1.3

16.7

1421

11474

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

16.7

445

2863

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

16.6

480

3151

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

16.6

1269

10078

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

16.6

361

2199

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.4

16.5

243

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

16.5

207

1045

I20.8

ICD-10 Finland

Other forms of angina pectoris

4.5

16.5

130

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.9

16.4

173

A10BJ01

ATC

exenatide; parenteral

4.8

16.4

113

C10AC02

ATC

colestipol; oral

10.1

16.4

UJD02

NOMESCO Finland

Gastroscopy

1.9

16.4

229

1207

Multi-vessel balloon catheter extension

5.0

16.3

105

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

16.3

685

4886

SPAT1301

SPAT

No procedures

1.3

16.3

1390

11218

C08CA07

ATC

nisoldipine; oral

3.3

16.3

246

3AC01

NOMESCO Finland

4.1

16.3

155

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

5.6

16.2

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.9

16.2

346

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

16.2

620

4342

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

16.0

561

3851

C03BA11

ATC

indapamide; oral

2.3

16.0

155

698

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.3

16.0

147

647

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

24.5

16.0

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

16.0

158

A06AD11

ATC

lactulose; oral

1.5

16.0

667

4756

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

15.9

231

1232

A10BJ05

ATC

dulaglutide; parenteral

4.9

15.9

104

R04.0

ICD-10 Finland

Epistaxis

1.7

15.9

344

2091

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

15.8

389

2447

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

15.8

278

1586

B01AC22

ATC

prasugrel; oral

7.7

15.8

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.1

15.8

274

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.4

15.8

135

575

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

11.2

15.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

15.7

273

1550

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

15.7

111

426

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.9

15.7

343

2728X

ICD-9 Finland

Disorders of lipoid metabolism, Other disorders of lipoid metabolism

+∞

15.6

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

15.6

N05AH04

ATC

quetiapine; oral

1.5

15.6

535

3655

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

15.5

326

1962

SPAT1054

SPAT

Examination of peripheral nervous system

2.8

15.5

345

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.9

15.5

167

H02AB04

ATC

methylprednisolone; systemic

1.5

15.5

598

4188

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

160.4

15.5

WX320

NOMESCO Finland

Spinalanesthesy

1.4

15.4

991

7640

A10BH02

ATC

vildagliptin; oral

2.6

15.4

111

428

E0000UV

ATC

1.3

15.4

1553

12819

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

15.3

277

1591

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

15.3

2122

18262

M79.1

ICD-10 Finland

Myalgia

1.6

15.3

453

2988

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

15.2

325

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

15.2

1653

13780

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.4

15.2

123

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

15.2

219

1167

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.1

15.1

142

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

15.1

844

6351

AXX01

SPAT

3.1

15.1

278

R01AD09

ATC

mometasone; nasal

1.3

15.0

1638

13651

C07AB03

ATC

atenolol; systemic

1.7

15.0

305

1819

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

3.5

14.9

204

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

14.9

1033

8056

Z01.7

ICD-10 Finland

Laboratory examination

1.6

14.9

431

2829

SPAT1097

SPAT

Recording of ECG

1.4

14.9

664

4792

V03AE02

ATC

sevelamer; oral

7.0

14.8

D82

ICPC

Teeth/gum disease

1.3

14.8

1186

9458

Z01.2

ICD-10 Finland

Dental examination

1.3

14.8

1461

12006

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

14.8

212

1127

N30.0

ICD-10 Finland

Acute cystitis

1.5

14.8

513

3510

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

14.8

119

491

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

56.8

14.8

Z50.0

ICD-10 Finland

Cardiac rehabilitation

3.3

14.8

227

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

5.6

14.7

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

14.7

139

621

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

14.7

2373

20778

J45

ICD-10 Finland

Asthma

1.6

14.7

354

2218

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

14.6

292

1733

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

14.6

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

14.6

383

2455

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

14.6

222

1206

SPAT1283

SPAT

Restricted health certificate

1.6

14.6

367

2327

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

3.5

14.5

198

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

5.1

14.5

R52.2

ICD-10 Finland

Other chronic pain

2.3

14.5

134

592

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

14.5

492

3351

WZB00

SPAT

2.4

14.4

122

515

AB2

AVR bio, stent

3.9

14.4

149

OAB44

SPAT

2.3

14.3

130

569

R00.2

ICD-10 Finland

Palpitations

1.8

14.3

239

1341

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

14.2

377

2421

P01AB01

ATC

metronidazole; oral, rectal

1.3

14.2

1485

12288

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.0

14.1

137

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.8

14.1

157

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

14.1

131

581

TK810

NOMESCO Finland

Hemofiltration

5.0

14.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

14.0

161

784

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

14.0

137

623

J01MA14

ATC

moxifloxacin; systemic

1.6

14.0

369

2362

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.2

14.0

144

669

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.2

14.0

231

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.2

14.0

231

104

Kela drug reimbursment

Thyroid insufficiency

1.7

14.0

270

1584

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.8

13.9

SPAT1342

SPAT

Referral to specialised care

3.6

13.9

174

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.3

13.9

216

K43

ICPC

Cardiovascular, Other diagnostic procedure

3.3

13.9

211

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

13.9

622

4489

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

13.8

169

846

R4190

NOMESCO Finland

Nutritional therapy

2.4

13.8

121

520

S01BC05

ATC

ketorolac; ophthalmic

1.9

13.8

200

1067

B01AB04

ATC

dalteparin; parenteral

1.8

13.8

225

1251

137

Kela drug reimbursment

Uraemia requiring dialysis

4.6

13.8

103

I11

ICD-10 Finland

Hypertensive heart disease

4.6

13.8

103

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.8

13.8

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.8

13.8

313

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.1

13.8

131

AS4

Physiological pacemaker insertion DDD (R)

2.8

13.7

323

EB1SA

SPAT

2.4

13.7

118

505

ANE

Coronary internal ultrasound (IVUS)

8.6

13.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

13.6

969

7573

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.4

13.6

198

I47.2

ICD-10 Finland

Ventricular tachycardia

2.5

13.6

105

425

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

13.6

114

482

C09CA07

ATC

telmisartan; oral

1.7

13.6

305

1872

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.5

442

2982

A01

ICPC

Pain general/multiple sites

1.7

13.5

300

1837

J01FA09

ATC

clarithromycin; systemic

1.3

13.5

1155

9282

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

4.4

13.5

110

SPAT1216

SPAT

Assessment of functional ability

1.4

13.5

705

5234

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

13.5

255

1490

J01CF05

ATC

flucloxacillin; systemic

2.1

13.4

157

774

342

Kela drug reimbursment

Dronedarone

4.0

13.4

130

R13

ICD-10 Finland

Dysphagia

1.7

13.3

278

1674

R06AE07

ATC

cetirizine; oral

1.3

13.3

1589

13350

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

13.3

413

2758

PE1AT

NOMESCO Finland

Femoral artery PTA

3.2

13.3

213

OAB50

SPAT

3.1

13.3

235

XG405

NOMESCO Finland

Education on PEF monitoring

3.1

13.3

235

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

13.3

449

3054

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

13.2

508

3552

C07BB07

ATC

bisoprolol and thiazides; systemic

1.9

13.2

189

1005

H25.8

ICD-10 Finland

Other senile cataract

1.5

13.2

548

3894

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

13.2

293

1796

C07AA07

ATC

sotalol; systemic

1.8

13.1

208

1146

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.1

1409

11677

K77

ICPC

Heart failure

2.4

13.1

107

444

D01AC02

ATC

miconazole; topical

1.6

13.1

348

2235

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

13.1

1751

14919

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

13.0

669

4950

TFP34

NOMESCO Finland

Electrophysiological investigation

2.2

13.0

130

598

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

13.0

659

4865

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

13.0

271

1629

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.8

12.9

291

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

12.9

390

2588

R06.5

ICD-10 Finland

Mouth breathing

1.6

12.9

335

2142

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

12.8

215

1208

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

12.8

362

2364

I95.9

ICD-10 Finland

Hypotension, unspecified

3.1

12.7

231

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

6.3

12.7

C01BD07

ATC

dronedarone; oral

4.3

12.7

108

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

12.7

378

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.7

12.7

312

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.7

12.7

312

R01AD08

ATC

fluticasone; nasal

1.3

12.6

1007

8000

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

12.6

216

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

12.6

307

1928

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

12.6

254

1514

U14

ICPC

Kidney symptom/complaint

2.9

12.6

267

K99

ICPC

Cardiovascular disease other

2.1

12.6

134

634

C02EA02

ATC

1.8

12.5

234

1360

27299

ICD-8 Finland

Congenital disorders of lipid metabolism, Unspecified

+∞

12.5

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

+∞

12.5

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

5.7

12.5

E83.50

ICD-10 Finland

Hypercalcemia

5.7

12.5

QDH

NOMESCO Finland

Operations on toe nails

17.3

12.5

Z49.2

ICD-10 Finland

Other dialysis

4.8

12.4

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.7

12.4

149

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

12.4

364

2394

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

12.4

247

1465

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

12.3

329

1CX08

NOMESCO Finland

5.6

12.3

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.5

12.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.6

12.3

151

I20.08

ICD-10 Finland

Unstable angina

10.5

12.2

B01AB10

ATC

tinzaparin; parenteral

1.7

12.2

277

1705

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

12.2

1521

12816

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

12.2

248

1480

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

12.2

173

921

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

7.4

12.2

P20

ICPC

Memory disturbance

1.4

12.1

600

4406

R03BA05

ATC

fluticasone; inhalant

1.4

12.1

653

4872

L03

ICPC

Low back symptom/complaint

1.3

12.1

892

7003

H05BX01

ATC

cinacalcet; oral

5.6

12.0

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

12.0

132

631

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

18.0

12.0

EBA00

SPAT

2.7

12.0

314

RJ420

NOMESCO Finland

6.6

12.0

SPAT1260

SPAT

Consultation of another employee

1.4

12.0

741

5657

K91

ICPC

Cerebrovascular disease

3.0

12.0

234

H02AB07

ATC

prednisone; oral

1.4

12.0

579

4234

H81

ICPC

Excessive ear wax

1.4

12.0

758

5808

B04AC04

ATC

4.1

11.9

110

R4130

NOMESCO Finland

Speech therapy

2.5

11.9

349

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

11.9

829

6447

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

7.5

11.9

SPAT1211

SPAT

Application of soft bandage

1.5

11.9

373

2497

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

11.9

386

2603

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.8

676

5092

WX213

NOMESCO Finland

Lower leg blockade

4.2

11.8

102

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.2

11.8

102

J01FA10

ATC

azithromycin; systemic

1.2

11.8

2069

18121

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

11.8

279

1741

D07AC13

ATC

mometasone; topical

1.3

11.7

1143

9328

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

9.6

11.7

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

7.3

11.7

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

11.7

313

2018

T90

ICD-10 Finland

Sequelae of injuries of head

6.0

11.6

R12

ICD-10 Finland

Heartburn

1.7

11.6

249

1513

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

11.5

411

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

11.5

411

WX290

SPAT

2.6

11.5

313

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

11.5

108

482

W19

ICD-10 Finland

Unspecified fall

1.5

11.5

364

2442

E78.21

ICD-10 Finland

Remnant hyperlipidemia

120.2

11.4

388

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

120.2

11.4

TK820

NOMESCO Finland

Peritoneal dialysis

6.7

11.4

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

11.4

215

1257

G45.3

ICD-10 Finland

Amaurosis fugax

2.5

11.4

333

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.0

11.4

137

684

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.3

11.4

102

446

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.3

11.3

172

C02DE04

ATC

2.0

11.3

141

713

K59.0

ICD-10 Finland

Constipation

1.7

11.3

232

1391

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

11.3

462

3269

A10BX09

ATC

[U] dapagliflozin; oral

3.6

11.3

136

H02AB09

ATC

hydrocortisone; systemic

2.6

11.3

317

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

11.3

107

481

E83.51

ICD-10 Finland

Hypocalcemia

15.0

11.3

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

11.3

998

8033

S06.0

ICD-10 Finland

Concussion

1.5

11.3

369

2495

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

11.2

229

1371

FL1AC

NOMESCO Finland

Left cardioangiography

2.6

11.2

305

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.0

11.2

112

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

11.2

188

1060

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

11.2

110

505

S22

ICPC

Nail symptom/complaint

1.7

11.2

232

1395

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.2

11.2

109

497

TDA90

SPAT

2.2

11.2

107

485

R03BA02

ATC

budesonide; inhalant

1.4

11.2

646

4875

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

4.6

11.2

K08.3

ICD-10 Finland

Retained dental root

1.6

11.2

281

1783

L04AA06

ATC

mycophenolic acid; systemic

2.9

11.1

230

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

11.1

178

987

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

11.1

363

2451

XF400

SPAT

4.0

11.1

108

R05

ICPC

Cough

1.3

11.1

830

6517

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

11.1

216

1276

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

11.1

406

2812

SPAT1104

SPAT

Monitoring of emergency patient

1.6

11.1

277

1752

A10BX02

ATC

repaglinide; oral

2.9

11.1

231

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

11.1

272

1714

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

11.1

428

2997

QXB99

SPAT

3.4

11.1

149

X58

ICD-10 Finland

Exposure to other specified factors

1.4

11.0

472

3370

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

11.0

2081

18327

WZA90

NOMESCO Finland

Other doctors statement

1.3

11.0

810

6346

J01CA08

ATC

pivmecillinam; oral

1.3

11.0

1278

10651

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

5.4

11.0

C09AA03

ATC

lisinopril; oral

1.7

11.0

220

1311

GD1LA

NOMESCO Finland

2.8

11.0

249

K84

ICPC

Heart disease other

2.1

10.9

122

590

K85

ICPC

Elevated blood pressure

1.4

10.9

650

4927

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

10.9

341

2283

R03AC03

ATC

terbutaline; inhalant

1.4

10.9

508

3691

A10BD03

ATC

metformin and rosiglitazone; systemic

2.6

10.9

316

B05DA

ATC

Isotonic solutions

4.6

10.9

A08

ICPC

Swelling

1.8

10.8

181

1018

L02

ICPC

Back symptom/complaint

1.6

10.8

290

1867

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.7

10.8

126

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.8

188

1072

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

10.8

240

1474

S29

ICPC

Skin symptom/complaint other

1.4

10.8

678

5184

C09DB01

ATC

valsartan and amlodipine; oral

2.0

10.8

137

701

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

2.9

10.8

218

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

10.7

219

1309

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

10.7

262

1647

FNG10

NOMESCO Finland

Embolectomy of coronary artery

7.2

10.7

C07AB12

ATC

nebivolol; oral

2.1

10.7

113

533

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

4.8

10.6

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.5

10.6

315

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

10.6

617

4654

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

10.6

432

3055

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.4

10.6

370

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.0

10.5

104

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

10.5

279

1794

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

10.5

109

510

FM1AT

NOMESCO Finland

Percutaneous implantation of aortic valve endoprosthesis

8.5

10.5

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

2.5

10.5

318

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.1

10.5

112

533

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

4.1

10.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.5

1837

16027

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

10.5

547

4054

M75

ICD-10 Finland

Shoulder lesions

1.8

10.5

161

884

S22.3

ICD-10 Finland

Fracture of rib

1.6

10.5

264

1676

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

10.4

172

967

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

10.4

116

564

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

10.4

371

2555

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

10.3

468

3379

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.8

10.3

111

R1260

NOMESCO Finland

Evaluation of communicative skills

2.5

10.3

326

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

10.3

124

619

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.3

1626

14021

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.2

10.3

N05BA01

ATC

diazepam; systemic, rectal

1.4

10.3

505

3702

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

10.3

157

857

J46

ICD-10 Finland

Status asthmaticus

2.1

10.3

108

512

M01AB01

ATC

indometacin; systemic, rectal

1.5

10.2

364

2505

M04AA03

ATC

febuxostat; oral

5.7

10.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

10.2

107

503

WZC30

SPAT

2.3

10.2

374

N17.8

ICD-10 Finland

Other acute renal failure

3.2

10.2

159

M54.2

ICD-10 Finland

Cervicalgia

1.6

10.2

242

1510

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

10.2

239

1489

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

10.2

173

980

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

7.4

10.2

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.3

10.1

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.9

10.1

103

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

10.1

171

965

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

10.1

264

1690

XF600

SPAT

3.4

10.1

139

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.2

10.1

166

288

Kela drug reimbursment

Febuxostat

5.4

10.1

H26.4

ICD-10 Finland

After-cataract

1.4

10.1

425

3028

G04CA02

ATC

tamsulosin; oral

1.3

10.1

1207

10078

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

6.9

10.1

WVA20

SPAT

3.3

10.0

145

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

10.0

163

911

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

10.0

344

2349

N05CD07

ATC

temazepam; oral

1.4

10.0

546

4074

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.5

10.0

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

10.0

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

3.7

9.9

115

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

9.9

379

A62

ICPC

General and Unspecified, Administrative procedure

2.1

9.9

112

545

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

9.9

136

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

9.9

216

1319

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

9.9

112

547

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.3

9.9

147

PD5AD

NOMESCO Finland

CT of aorta

2.5

9.9

286

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.9

9.9

134

704

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

9.8

248

1573

M14.6

ICD-10 Finland

Neuropathic arthropathy

12.2

9.8

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.0

9.8

119

599

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

9.8

262

1687

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

9.8

112

550

Z72.0

ICD-10 Finland

Tobacco use

2.3

9.8

374

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.2

9.8

D07AB08

ATC

desonide; topical

1.5

9.8

385

2703

RJ410

NOMESCO Finland

5.9

9.8

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.2

9.8

436

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

2.8

9.8

210

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.7

812

6474

M02AA07

ATC

piroxicam; topical

1.2

9.7

1581

13660

S80.0

ICD-10 Finland

Contusion of knee

1.7

9.7

199

1196

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

9.7

282

1856

B60

ICPC

Blood and Immunity, Result test/procedure

2.6

9.7

269

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

9.7

262

1695

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.6

9.7

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.9

9.7

193

127

Kela drug reimbursment

Transplant complication

2.9

9.7

193

QBJ30

NOMESCO Finland

Correction of abdominal apron

6.1

9.7

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

9.6

210

1285

XCK00

NOMESCO Finland

Perimetry

1.5

9.6

287

1902

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

9.6

110

542

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

3.9

9.6

A99

ICPC

Disease/condition unspecnature/site

1.5

9.6

315

2134

E73.9

ICD-10 Finland

Lactose intolerance, unspecified

8.4

9.5

RD112

NOMESCO Finland

8.4

9.5

S17

ICPC

Abrasion/scratch/blister

2.2

9.5

407

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

2.3

9.5

368

J01MA06

ATC

norfloxacin; oral

1.4

9.5

521

3893

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.4

9.5

E23.00

ICD-10 Finland

Panhypopituitarism

5.4

9.5

S20.2

ICD-10 Finland

Contusion of thorax

1.7

9.5

176

1027

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

9.5

296

1979

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.5

764

6057

K29

ICPC

Cardiovascular sympt/complt other

1.7

9.5

190

1135

R03DC03

ATC

montelukast; oral

1.4

9.4

510

3800

E000001

ATC

1.3

9.4

737

5818

SPAT1251

SPAT

Organisation of medication

1.8

9.4

158

894

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.5

9.4

275

E78.3

ICD-10 Finland

Hyperchylomicronaemia

100.2

9.4

SPAT1139

SPAT

Nutrition survey

1.9

9.4

128

673

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

9.4

297

1994

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

9.4

403

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

30.0

9.4

RJ122

NOMESCO Finland

30.0

9.4

I20.19

ICD-10 Finland

Angina angiospastic

4.9

9.4

N17

ICPC

Vertigo/dizziness

1.4

9.4

432

3128

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

9.4

140

761

A03FA02

ATC

cisapride; oral, rectal

1.5

9.4

317

2159

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.8

9.3

205

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

3.1

9.3

154

L12

ICPC

Hand/finger symptom/complaint

1.4

9.2

486

3607

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

9.2

254

1652

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.2

670

5233

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

9.2

272

1796

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.9

9.2

182

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.8

9.2

211

E79.0

ICD-10 Finland

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

13.7

9.2

M01AB55

ATC

diclofenac, combinations; oral

1.5

9.2

294

1979

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

9.1

144

798

J01EA01

ATC

trimethoprim; systemic

1.3

9.1

930

7599

PD4DG

NOMESCO Finland

Very extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.2

9.1

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.3

9.1

135

RK250

NOMESCO Finland

4.3

9.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

9.1

133

717

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.1

9.0

152

SPAT1053

SPAT

Memory test

1.3

9.0

759

6050

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

9.0

209

1297

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

9.0

137

750

H3603, E107

ICD-10 Finland

15.6

9.0

E24.8

ICD-10 Finland

Other Cushing syndrome

36.7

9.0

ZY010

SPAT

3.1

9.0

147

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

9.0

114

582

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.6

9.0

239

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

9.0

123

650

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

9.0

459

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

9.0

159

916

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

8.9

423

3079

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

8.9

130

701

R52.0

ICD-10 Finland

Acute pain

2.1

8.9

100

487

V03AE03

ATC

lanthanum carbonate; oral

7.4

8.9

3025

Kela drug reimbursment

Calcium carbonate

7.4

8.9

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

8.9

M54.8

ICD-10 Finland

Other dorsalgia

1.9

8.9

128

688

S10

ICPC

Boil/carbuncle

1.7

8.9

191

1162

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

8.9

217

1369

RS220

NOMESCO Finland

2.9

8.9

175

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

12.5

8.8

S21

ICPC

Skin texture symptom/complaint

1.4

8.8

493

3693

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

8.8

228

M01AC01

ATC

piroxicam; systemic, rectal

1.3

8.8

556

4251

FP1B5

SPAT

3.8

8.8

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

8.8

187

1138

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

8.6

8.8

SPAT1234

SPAT

Support of social functional capacity

1.6

8.8

210

1319

K92.1

ICD-10 Finland

Melaena

1.6

8.8

224

1429

L08

ICPC

Shoulder symptom/complaint

1.3

8.7

739

5897

N18

ICD-10 Finland

Chronic kidney disease

2.9

8.7

178

349

Kela drug reimbursment

Febuxostat

5.6

8.7

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

8.7

363

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

8.7

186

1133

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.7

8.7

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

3.7

8.7

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

3.7

8.7

J01

ICD-10 Finland

Acute sinusitis

1.8

8.7

138

768

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

50.0

8.7

D11

ICPC

Diarrhoea

1.5

8.6

301

2063

N06AX03

ATC

mianserin; oral

1.7

8.6

184

1120

AQ1

Conventional electrophysiological examination

2.7

8.6

209

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.9

8.6

173

C01BC04

ATC

flecainide; systemic

1.7

8.6

158

921

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

8.6

453

3361

N06AB06

ATC

sertraline; oral

1.5

8.6

312

2158

C01CA24

ATC

epinephrine; parenteral

1.7

8.6

161

944

N03AE01

ATC

clonazepam; systemic

1.6

8.6

213

1351

PD3AT

NOMESCO Finland

Pelvic artery PTA

3.7

8.6

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

2.3

8.6

327

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

2.9

8.6

174

A07AA02

ATC

nystatin; oral

1.5

8.6

247

1624

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.0

8.6

105

533

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

8.6

380

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

8.6

336

H3602, E103

ICD-10 Finland

11.6

8.6

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

8.5

155

898

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.9

8.5

M86.6

ICD-10 Finland

Other chronic osteomyelitis

4.8

8.5

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.6

8.5

229

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

8.5

264

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.9

8.5

M15

ICD-10 Finland

Polyarthrosis

1.6

8.5

189

1166

WNF00

NOMESCO Finland

Infection source and contact determination

4.5

8.4

S76

ICPC

Skin infection other

1.7

8.4

185

1132

K01

ICPC

Heart pain

2.5

8.4

248

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

8.4

448

3330

UJF32

SPAT

2.4

8.4

285

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

8.4

250

1657

D10

ICPC

Vomiting

1.9

8.4

118

628

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.1

8.4

138

D07AD01

ATC

clobetasol; topical

1.3

8.4

571

4413

292

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

90.2

8.4

R06.4

ICD-10 Finland

Hyperventilation

2.7

8.4

200

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.7

8.4

183

1119

TFP35

NOMESCO Finland

Electroanatomical mapping

2.5

8.4

241

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

8.4

166

990

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.4

8.4

268

R51.81

ICD-10 Finland

Facial pain NOS

2.2

8.4

358

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

8.3

169

1013

E03

ICD-10 Finland

Other hypothyroidism

1.6

8.3

189

1169

N03AX09

ATC

lamotrigine; oral

1.9

8.3

113

593

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

+∞

8.3

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

8.3

172

1036

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

8.3

413

3035

A10BB07

ATC

glipizide; oral

2.3

8.3

308

C02DE02

ATC

2.2

8.3

360

I95.2

ICD-10 Finland

Hypotension due to drugs

3.5

8.3

102

L15

ICPC

Knee symptom/complaint

1.3

8.3

784

6343

1DC02

NOMESCO Finland

5.0

8.3

M01AH02

ATC

rofecoxib; oral

1.3

8.3

555

4278

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

8.3

184

1134

XQ800

NOMESCO Finland

Prick test

1.6

8.3

195

1218

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

8.3

491

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.5

8.2

237

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

8.2

443

XCD20

NOMESCO Finland

Photoangiography of eye

2.2

8.2

386

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

4.7

8.2

Z00.8

ICD-10 Finland

Other general examinations

1.5

8.2

241

1590

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

8.2

241

1593

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

8.2

124

679

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.5

8.2

N18

ICPC

Paralysis/weakness

2.2

8.2

368

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

4.5

8.1

J01DA06

ATC

[U] cefuroxime; systemic

1.3

8.1

517

3957

KH1EE

NOMESCO Finland

Urologic ultrasound examination

5.4

8.1

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

8.1

310

2166

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

8.1

318

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.4

8.1

287

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.0

8.1

148

B04AC01

ATC

8.1

Z95

ICD-10 Finland

Presence of cardiac and vascular implants and grafts

17.2

8.1

E26.0

ICD-10 Finland

Primary hyperaldosteronism

4.2

8.1

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.8

8.0

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

3.9

8.0

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

8.0

171

1043

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.3

8.0

116

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

8.0

211

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

8.0

356

2566

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

8.0

354

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

3.3

8.0

111

I63

ICD-10 Finland

Cerebral infarction

3.1

8.0

133

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

7.2

7.9

R80

ICD-10 Finland

Isolated proteinuria

3.5

7.9

101

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.8

7.9

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

7.9

118

646

B05DB

ATC

Hypertonic solutions

4.2

7.9

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

2.4

7.9

278

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.9

294

2046

K92

ICPC

Atherosclerosis/periph vascular dis

2.5

7.8

233

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

7.8

107

564

ANB

Coronary thrombectomy

5.1

7.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

7.8

208

1344

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

7.8

319

2259

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.9

7.8

155

N06AB03

ATC

fluoxetine; oral

1.4

7.8

407

3018

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

7.8

1522

13326

171

Kela drug reimbursment

Degludekinsuliini

10.8

7.8

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.3

7.8

300

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.4

7.8

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.8

944

7869

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

6.9

7.8

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.6

7.7

200

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

7.7

163

989

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

7.7

494

3784

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

7.7

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.0

7.7

142

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

7.7

137

794

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.7

7.7

188

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.7

582

4569

R30.0

ICD-10 Finland

Dysuria

1.8

7.7

118

652

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

7.7

393

2906

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

7.4

7.7

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.5

7.7

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.0

7.7

137

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.6

7.7

182

1141

N07CA01

ATC

betahistine; oral

1.4

7.6

307

2170

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

7.6

215

1408

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

7.6

152

910

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.8

7.6

119

658

U71

ICPC

Cystitis/urinary infection other

1.6

7.6

199

1278

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

7.6

180

1129

SPAT1172

SPAT

Guidance concerning hydration

1.9

7.6

101

528

K04.0

ICD-10 Finland

Pulpitis

1.5

7.6

240

1612

PC5CG

NOMESCO Finland

Extensive MRI examination of kidney vasculature with high intensity magnet

6.7

7.6

D07AC01

ATC

betamethasone; topical

1.2

7.6

1353

11741

T99

ICPC

Endocr/metab/nutrit disease other

2.4

7.6

243

J45.8

ICD-10 Finland

Mixed asthma

1.9

7.5

103

546

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

2.1

7.5

378

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.5

7.5

214

1405

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.6

7.5

191

G54.0

ICD-10 Finland

Brachial plexus disorders

2.4

7.5

263

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

7.5

368

2697

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

7.5

443

3350

Catheterization and pressure measurement of the left side of the heart

2.1

7.5

379

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.7

7.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

7.5

122

687

RD211

NOMESCO Finland

0.5

7.5

1054

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.5

436

3294

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.1

7.5

384

M01AX05

ATC

glucosamine; oral

1.2

7.5

910

7587

A60

ICPC

General and Unspecified, Result test/procedure

1.6

7.4

164

1011

N19

ICPC

Speech disorder

2.6

7.4

186

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.7

7.4

152

917

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.2

7.4

318

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

7.4

251

1713

FNA96

NOMESCO Finland

Other connection to coronary artery from internal mammary artery

5.0

7.4

B04AD02

ATC

7.6

7.4

H53.2

ICD-10 Finland

Diplopia

1.8

7.4

115

636

G72.9

ICD-10 Finland

Myopathy, unspecified

3.2

7.4

113

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.4

203

1325

R33

ICD-10 Finland

Retention of urine

1.4

7.4

354

2589

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

5.3

7.4

I21

ICD-10 Finland

Acute myocardial infarction

6.0

7.4

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

7.4

321

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

7.3

507

8113

FHL

Fractional scraping

1.5

7.3

234

1580

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.3

152

919

RJ120

NOMESCO Finland

8.4

7.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

7.3

444

27288

ICD-8 Finland

Congenital disorders of lipid metabolism, Alii defeniti

+∞

7.3

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.8

7.3

159

T43

ICPC

Metabolic, Other diagnostic procedure

10.9

7.3

SPAT1236

SPAT

Informing family of child’s disability

2.0

7.3

445

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

7.3

350

2559

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.1

7.3

396

M48.9

ICD-10 Finland

Spondylopathy, unspecified

3.5

7.2

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

7.2

120

681

M19.8

ICD-10 Finland

Other specified arthrosis

1.8

7.2

125

716

K74

ICPC

Ischaemic heart dis with angina

2.5

7.2

219

C09DA07

ATC

telmisartan and diuretics; oral

1.6

7.2

160

989

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

7.2

102

546

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

7.2

132

770

G72.8

ICD-10 Finland

Other specified myopathies

2.3

7.2

257

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

7.2

370

2735

SPAT1312

SPAT

General health counselling

1.2

7.2

1208

10409

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

7.2

1230

10620

FNE96

NOMESCO Finland

Coronary bypass using other free arterial graft

7.3

7.2

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

7.2

174

1100

F32

ICD-10 Finland

Depressive episode

1.8

7.2

123

705

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

1.9

7.1

479

N06AA04

ATC

clomipramine; systemic

2.2

7.1

299

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

7.1

436

3315

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

30.0

7.1

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

3.7

7.1

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

20.0

7.1

C08CA10

ATC

nilvadipine; oral

2.0

7.1

457

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

7.1

140

835

K04

ICD-10 Finland

Diseases of pulp and periapical tissues

3.2

7.1

111

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

7.9

7.1

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

7.1

294

2092

H03BB01

ATC

carbimazole; oral

1.8

7.1

111

618

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

7.1

143

859

QBB10

SPAT

5.3

7.1

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

3.5

7.0

SPAT1255

SPAT

Intravenous administration of medicine

1.5

7.0

254

1760

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

8.8

7.0

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

3.6

7.0

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

3.7

7.0

C09DX04

ATC

valsartan and sacubitril; oral

3.0

7.0

123

WX950

SPAT

10.0

7.0

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

7.0

114

641

Z04

ICD-10 Finland

Examination and observation for other reasons

2.2

7.0

295

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.4

7.0

293

2087

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

7.0

121

694

PH3AC

NOMESCO Finland

Flebography of internal organs with X-ray

7.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.2

7.0

287

I84

ICD-10 Finland

Hemorrhoids

1.9

7.0

102

553

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

7.0

270

1895

H93.1

ICD-10 Finland

Tinnitus

1.5

7.0

234

1595

N07BA03

ATC

varenicline; oral

1.7

6.9

135

803

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

6.9

222

1497

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

6.9

736

6036

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

6.9

147

898

RJ210

NOMESCO Finland

6.3

6.9

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.5

6.9

194

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

5.1

6.9

RJ414

NOMESCO Finland

5.8

6.9

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

6.9

312

2259

M54.3

ICD-10 Finland

Sciatica

1.5

6.9

199

1314

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

6.9

125

0088X

ICD-9 Finland

Intestinal infections due to other organisms, Other organism, not elsewhere classified

4.6

6.9

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

6.9

302

2173

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

6.8

688

5605

K07

ICPC

Swollen ankles/oedema

1.6

6.8

175

1120

L16

ICPC

Ankle symptom/complaint

1.4

6.8

322

2346

40199

ICD-8 Finland

Essential benign hypertension

1.9

6.8

493

L28.1

ICD-10 Finland

Prurigo nodularis

3.3

6.8

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.7

6.8

120

694

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

8.3

6.8

XX3CW

NOMESCO Finland

8.3

6.8

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

6.8

375

I49.1

ICD-10 Finland

Atrial premature depolarization

1.7

6.8

130

768

M54.1

ICD-10 Finland

Radiculopathy

1.7

6.8

127

749

H26.02

ICD-10 Finland

Presenil cataract

1.8

6.8

101

554

R05DA01

ATC

ethylmorphine; oral

1.4

6.8

294

2109

XA420

NOMESCO Finland

Extensive sleep examination

2.6

6.8

173

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

6.8

171

1091

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

2.1

6.8

367

A10BD20

ATC

metformin and empagliflozin; systemic

2.7

6.8

166

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

40.1

6.8

A08AB01

ATC

orlistat; oral

2.9

6.7

136

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

3.2

6.7

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

6.7

368

L84

ICD-10 Finland

Corns and callosities

1.7

6.7

123

721

SPAT1252

SPAT

Overall medication plan or its review

1.4

6.7

288

2063

BC1AD

NOMESCO Finland

CT of adrenal glands

2.7

6.7

150

E000003

ATC

1.6

6.7

145

891

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

6.7

327

2395

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

6.7

174

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.3

6.7

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

7.2

6.7

N05BA12

ATC

alprazolam; oral

1.4

6.7

336

2475

R10.0

ICD-10 Finland

Acute abdomen

1.8

6.7

100

550

RJ513

NOMESCO Finland

22.5

6.7

T89

ICD-10 Finland

22.5

6.7

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.7

6.7

151

RS222

NOMESCO Finland

2.5

6.7

193

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.0

6.6

426

A10AA03

ATC

2.8

6.6

139

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

6.4

6.6

EBA30

NOMESCO Finland

Excision of root of tooth

1.5

6.6

193

1279

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.3

6.6

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

6.6

1370

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.6

247

1725

N17

ICD-10 Finland

Acute renal failure

5.9

6.6

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.2

6.6

284

QDB10

SPAT

3.4

6.6

J01MA01

ATC

ofloxacin; systemic

1.4

6.6

353

2630

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

6.6

101

560

D09

ICPC

Nausea

1.8

6.6

530

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.8

6.6

140

A87

ICPC

Complication of medical treatment

2.9

6.6

133

R35

ICD-10 Finland

Polyuria

1.4

6.6

255

1795

R28

ICPC

Limited function/disability (R)

2.4

6.6

225

A10BD05

ATC

metformin and pioglitazone; systemic

3.6

6.5

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.9

6.5

N01

ICPC

Headache

1.5

6.5

226

1553

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

6.5

189

F1279

NOMESCO Finland

10.0

6.5

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.6

6.5

181

D02AX

ATC

Other emollients and protectives

1.9

6.5

523

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

1.9

6.5

465

SCF01

NOMESCO Finland

Preventive oral care by dental hygienist or dental assistant, restricted

1.8

6.5

100

554

KGH10

NOMESCO Finland

Operation for phimosis

1.8

6.5

104

585

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

4.1

6.5

SPAT1060

SPAT

Administration of oxygen

4.1

6.5

R03AC13

ATC

formoterol; inhalant

1.5

6.5

182

1193

J02AC01

ATC

fluconazole; systemic

1.2

6.5

1217

10584

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

2737

15148

2.57

256.16

5.0

3.8

mg/mmol

16.6

7.2

10.01

1915

9356

(3012516) Albumin [Mass/volume] in Urine

2619

14374

2.53

247.05

4.2

3.1

mg/l

236.2

358.0

1.11

1897

9027

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2635

14831

2.46

230.93

3.8

2.9

ng/l

2074.8

1479.0

5.24

2317

12734

(3009508) Creatinine [Moles/volume] in Urine

2610

14684

2.45

228.21

4.1

3.0

mmol/l

7.2

7.6

5.90

2181

12041

(3000991) Gas panel - Venous blood

977

3690

2.99

187.21

10.6

7.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1404

6438

2.57

184.45

3.4

2.2

g/l

2.3

0.12

1306

5883

(3022948) Iron [Moles/volume] in Serum or Plasma

1478

6983

2.51

181.94

3.4

2.2

umol/l

11.6

12.7

7.58

1386

6378

(3002032) Base excess in Venous blood by calculation

1020

4066

2.84

176.22

5.8

3.2

mmol/l

1.5

2.0

4.19

900

3261

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1326

6045

2.56

175.30

3.5

2.3

20.1

22.4

8.85

1223

5062

(3013826) Glucose [Moles/volume] in Serum or Plasma

3819

27065

2.27

174.54

7.0

4.3

mmol/l

7.4

6.8

45.10

3666

25288

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1013

4093

2.80

170.12

5.9

3.2

kpa

5.8

0.08

994

3964

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1220

5429

2.59

168.96

8.9

4.8

mmol/l

1.1

1.0

12.18

1133

4985

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2305

13822

2.13

156.24

2.6

2.0

u/l

219.6

220.2

0.01

2175

12812

(3020779) Urea [Moles/volume] in Serum or Plasma

945

3920

2.69

149.32

10.4

5.8

mmol/l

12.5

10.2

14.23

886

3709

(3014576) Chloride [Moles/volume] in Serum or Plasma

1240

5904

2.41

146.21

9.0

6.4

mmol/l

104.2

104.5

1.53

1228

5795

(3024354) Oxygen [Partial pressure] in Venous blood

845

3413

2.74

140.11

4.5

2.6

kpa

4.6

4.5

0.50

821

3291

(3033658) Prothrombin time (PT) actual/Normal

1920

11109

2.10

139.40

5.0

3.8

85.5

86.0

0.27

1890

10840

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2770

18306

2.01

138.99

5.9

3.5

ng/l

95.7

82.4

0.14

2236

13699

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3358

23828

2.01

136.48

6.2

6.1

umol/l

12.0

12.2

0.25

3212

22555

(3044640) Blood type and Crossmatch panel - Blood

2282

14235

2.01

133.34

3.0

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3298

23429

1.98

131.48

9.9

5.9

mmol/l

1.2

3.76

2877

19504

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3069

21320

1.96

130.08

9.6

5.3

mmol/l

1.2

5.00

2800

18983

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2906

19831

1.96

129.68

2.4

2.0

pmol/l

94.0

93.5

0.20

1550

10306

(3014111) Lactate [Moles/volume] in Serum or Plasma

909

3974

2.53

127.54

8.9

6.1

mmol/l

1.4

0.20

881

3826

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1319

6838

2.21

124.92

2.6

1.9

30.6

30.1

1.84

1289

6610

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2540

16735

1.94

123.99

3.7

2.6

ug/l

181.6

159.2

0.50

2297

15088

(3022217) INR in Platelet poor plasma by Coagulation assay

1317

6855

2.20

123.29

33.2

28.1

inr

1.4

1.5

0.23

144

949

(3032080) INR in Blood by Coagulation assay

2870

19786

1.92

121.24

12.7

9.7

inr

1.4

1.3

0.90

624

5463

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

756

3099

2.66

120.69

6.1

3.3

ng/l

128.3

90.8

11.37

652

2600

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1916

11559

2.00

120.21

2.6

2.2

mg/l

3.2

3.1

1.49

1625

9770

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1333

7071

2.16

118.33

3.4

3.0

mmol/l

0.8

0.10

1248

6533

(3024561) Albumin [Mass/volume] in Serum or Plasma

2898

20156

1.90

117.98

5.6

4.5

g/l

34.7

35.0

1.88

2701

18495

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1355

7284

2.13

115.90

3.6

3.0

e6/l

2.4

2.0

0.83

722

4068

(3023368) Bacteria identified in Blood by Culture

2115

13337

1.94

115.51

5.3

4.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

550

1957

3.01

114.41

6.4

3.4

mmol/l

23.9

24.2

1.39

491

1717

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1447

8013

2.08

114.17

3.4

2.8

e6/l

1.2

1.4

0.35

812

4762

(3026493) Urate [Moles/volume] in Serum or Plasma

1947

11999

1.95

113.38

3.6

2.6

umol/l

6665.1

5396.5

0.51

1658

10175

(3018095) Leukocytes [#/volume] in Urine

2430

16265

1.87

108.60

5.0

3.6

e6/l

95.7

108.0

0.23

1805

11839

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1807

11015

1.94

107.51

2.9

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

2195

14276

1.88

106.97

4.1

3.1

e6/l

71.7

97.8

0.46

1706

11022

(3030467) Casts [#/volume] in Urine by Automated count

2065

13221

1.89

105.29

4.0

3.1

e6/l

0.4

0.5

0.33

1558

10068

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1995

12952

1.84

94.97

3.3

3.1

u/l

34.5

34.9

0.11

1895

12133

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1501

8910

1.93

94.49

5.2

3.6

ng/l

613.4

605.7

0.01

1301

7438

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

541

2108

2.73

94.46

4.0

2.3

0.7

0.86

520

2000

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4327

35475

1.94

93.65

9.1

7.3

u/l

83.1

79.2

5.16

4106

33064

(3013650) Neutrophils [#/volume] in Blood by Automated count

3350

25432

1.78

92.84

9.1

8.7

e9/l

4.5

4.2

12.36

2822

22049

(3013115) Eosinophils [#/volume] in Blood

3023

22392

1.75

90.15

6.8

5.7

e9/l

0.2

1.68

2552

19403

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

678

3024

2.41

89.14

11.0

8.0

1.4

0.12

672

3009

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

674

3005

2.41

88.67

11.1

8.1

0.7

1.04

668

2988

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

534

2137

2.66

88.26

1.7

g/l

1.6

1.5

0.94

466

1808

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

583

2439

2.55

87.97

10.9

8.4

mmol/l

24.5

24.4

0.54

533

2241

(3018418) pH of Serum or Plasma

2048

13667

1.78

87.13

5.8

3.6

7.4

0.37

291

2633

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4864

41892

2.17

86.91

9.5

5.9

mmol/mol

45.3

40.1

146.69

4496

37850

(3004119) Hemoglobin [Mass/volume] in Venous blood

628

2744

2.45

86.27

4.6

2.8

g/l

127.3

128.7

0.78

618

2676

(3006315) Basophils [#/volume] in Blood

2931

21719

1.73

85.46

6.6

5.5

e9/l

0.0

1.21

2437

18557

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

875

4418

2.16

85.34

2.8

2.3

ug/l

8.8

7.4

0.99

746

3823

(3001604) Monocytes [#/volume] in Blood

2910

21576

1.72

84.17

6.6

5.5

e9/l

0.6

5.41

2422

18413

(36304419) Bacteria [Presence] in Urine

1927

12735

1.78

84.05

4.0

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1028

5561

2.04

83.30

2.7

2.4

1.9

1.7

4.51

920

4859

(4034850)

410

1485

2.90

81.87

10.8

10.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1481

9101

1.85

81.85

1.9

1.6

mg/l

1.5

1.4

0.21

1158

7021

(3003396) Base excess in Arterial blood by calculation

1003

5410

2.04

81.79

8.7

6.7

mmol/l

0.6

1.1

3.08

822

4183

(3027801) Oxygen [Partial pressure] in Arterial blood

1006

5448

2.03

81.06

8.7

6.6

kpa

11.1

12.1

9.03

962

5166

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1006

5449

2.03

81.01

8.7

6.6

kpa

5.1

0.22

963

5174

(3019198) Lymphocytes [#/volume] in Blood

2955

22146

1.70

80.87

6.7

5.6

e9/l

1.9

0.06

2526

19250

(3009343) pH of Capillary blood

631

2849

2.37

80.31

4.7

3.4

7.4

0.10

368

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5032

44252

2.26

79.92

24.6

14.5

mg/l

26.2

26.5

0.24

4395

35241

(3021960) Folate [Moles/volume] in Serum or Plasma

1753

11431

1.77

79.02

1.8

1.5

nmol/l

19.3

20.4

2.52

1499

9569

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

634

2898

2.34

78.36

4.7

3.4

kpa

5.1

5.2

0.66

574

2653

(3011397) Hemoglobin [Presence] in Urine by Test strip

1636

10495

1.79

77.76

4.2

3.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

608

2752

2.36

76.79

4.7

3.3

mmol/l

1.3

1.9

3.02

447

2050

(3019309) Folate [Moles/volume] in Red Blood Cells

1538

9761

1.79

75.40

1.8

1.7

nmol/l

1128.8

1168.3

0.88

1171

7178

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4644

39908

1.92

74.88

5.7

4.4

mu/l

2.0

2.1

0.85

4194

35444

(3019069) Monocytes/100 leukocytes in Blood

2725

20281

1.66

74.08

7.3

6.1

8.9

0.08

2543

18732

(3031040) Bacteria [#/volume] in Urine by Automated count

3742

30242

1.70

73.99

5.8

4.5

e6/l

345.8

2419.7

4.38

418

(3006504) Eosinophils/100 leukocytes in Blood

2711

20161

1.66

73.83

7.0

5.8

2.8

2.9

0.42

2528

18559

(3022096) Basophils/100 leukocytes in Blood

2649

19596

1.66

73.54

7.0

5.8

0.7

0.28

2463

18061

(3002030) Lymphocytes/100 leukocytes in Blood

2765

20693

1.66

73.26

7.2

5.9

25.3

26.7

8.42

2563

18990

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

886

4756

2.02

72.47

2.6

2.7

umol/l

7.1

9.7

5.96

790

4138

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

982

5467

1.96

72.38

3.4

4.3

u/l

247.2

246.8

0.02

918

5144

(3026008) Bacteria identified in Urine by Culture

2025

14022

1.69

72.01

3.6

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2419

17551

1.66

71.89

2.8

2.1

nmol/l

75.5

79.7

10.86

2105

15257

(3018010) Neutrophils/100 leukocytes in Blood

2725

20382

1.65

71.85

6.9

5.7

59.1

58.0

4.78

2541

18813

(3026782) Osmolality of Urine

1450

9157

1.79

71.69

3.3

2.7

mosm/kgh2o

544.1

564.3

3.06

1262

7708

(3016502) Oxygen saturation in Arterial blood

893

4868

1.99

69.72

9.3

7.0

94.5

95.5

3.79

868

4675

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

411

1626

2.65

69.05

3.6

2.8

u/ml

0.3

0.61

229

905

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1263

7747

1.81

68.41

2.0

1.8

—

(40758558) Short blood count panel - Blood

1662

11038

1.72

68.19

6.5

—

(42870588) Differential panel, method unspecified - Blood

2115

14990

1.66

67.71

6.6

5.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

652

3205

2.17

67.09

2.6

2.3

nmol/l

359.8

370.1

0.58

589

2923

(3027273) Bicarbonate [Moles/volume] in Venous blood

504

2245

2.37

65.65

4.9

2.9

mmol/l

25.1

25.2

0.49

499

2179

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2742

20860

1.61

65.10

4.7

4.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2020

14275

1.65

64.64

3.2

2.4

u/l

57.5

59.5

0.64

1870

13062

(3020630) Protein [Mass/volume] in Serum or Plasma

757

4017

2.02

63.34

2.2

2.4

g/l

66.0

66.4

0.66

686

3586

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3870

32123

1.65

63.32

4.5

3.7

pmol/l

15.0

0.12

3473

28368

(3002173) Hemoglobin [Mass/volume] in Arterial blood

814

4447

1.97

62.65

9.9

7.4

g/l

118.8

121.0

2.22

798

4279

(3037467) Urinalysis macro (dipstick) panel - Urine

3776

31192

1.64

62.56

5.5

4.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

737

3892

2.03

62.45

2.8

2.4

u/l

40.2

52.8

0.44

622

3321

(3023520) Reticulocytes [#/volume] in Blood

782

4238

1.98

61.52

2.7

2.6

e9/l

71.9

67.8

2.40

540

3235

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

583

2834

2.18

61.46

1.8

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5186

47075

2.25

61.31

30.5

16.8

mmol/l

139.5

139.7

11.80

5094

45712

(3023103) Potassium [Moles/volume] in Serum or Plasma

5188

47184

2.23

59.63

30.7

16.9

mmol/l

4.0

9.41

5094

45744

(3022313) Gas panel - Capillary blood

464

2077

2.34

59.60

5.1

3.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

311

1151

2.80

59.36

2.5

2.2

ug/min

133.5

83.9

1.15

197

642

(3042936) Bacteria identified in Isolate by Culture

1058

6452

1.79

57.21

2.5

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3927

33079

1.62

56.88

4.9

4.0

mm/h

16.1

13.1

22.27

3583

30068

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4766

42252

1.82

56.85

23.0

13.7

ml/min/173m2

71.5

75.9

32.27

4172

34843

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4975

44745

1.94

56.12

7.2

5.0

mmol/l

2.3

2.7

149.26

4579

40110

(3004588) Protein electrophoresis panel - Serum or Plasma

638

3337

2.03

55.15

2.1

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

378

1610

2.44

54.16

2.7

2.2

ug/l

637.7

647.6

0.02

356

1528

(3052851) Hemolysis interference index of Serum or Plasma

330

1319

2.60

54.09

3.8

3.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

892

5250

1.83

53.98

1.8

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

2772

21739

1.54

53.56

6.3

4.9

estimate

0.0

0.50

384

4153

(3009261) Glucose [Presence] in Urine by Test strip

2799

22020

1.54

53.14

4.6

3.8

estimate

0.0

1.85

354

4047

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

534

2663

2.11

52.39

1.6

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

889

5272

1.81

52.35

1.8

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1089

6852

1.73

52.27

1.6

1.4

g/l

2.6

0.03

635

3951

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3251

26519

1.53

51.49

3.7

3.0

u/l

67.9

52.6

11.50

2995

24078

(3000850) Epithelial cells [#/volume] in Urine

1480

10129

1.63

51.36

3.1

2.5

e6/l

4.6

0.00

1321

8795

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

224

752

3.06

50.96

2.6

1.6

nmol/l

0.9

0.8

1.38

163

625

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4686

41716

1.73

50.19

5.7

4.0

mmol/l

1.5

1.3

57.32

4211

36984

(3035350) Ketones [Presence] in Urine by Test strip

2743

21694

1.51

49.39

4.5

3.7

estimate

0.0

0.50

373

4126

(3017143) Hepatitis C virus Ab [Presence] in Serum

636

3462

1.94

48.74

1.9

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

398

1827

2.27

47.95

5.8

3.6

mmol/l

24.3

25.0

3.17

358

1662

(3007853) Bacteria identified in Skin by Aerobe culture

860

5195

1.77

47.19

2.2

1.7

—

(3021589) Normoblasts [#/volume] in Blood

2494

19462

1.50

47.09

11.4

9.5

e9/l

0.0

1.81

1928

15951

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4828

43610

1.74

45.63

6.3

4.5

mmol/l

4.2

4.6

128.44

4443

39338

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

664

3755

1.87

45.12

1.9

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

827

5001

1.77

45.05

1.3

titre

565.6

526.7

0.20

158

1052

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5139

47393

1.94

44.05

14.5

10.4

u/l

27.6

25.8

5.97

4969

45204

(3015377) Calcium [Moles/volume] in Serum or Plasma

2092

15914

1.50

43.72

3.4

mmol/l

2.4

1.31

1736

13616

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

580

3185

1.92

43.05

1.7

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4778

43222

1.69

42.57

6.3

4.4

mmol/l

1.3

1.5

124.83

4343

38705

(3024928) Oxygen saturation in Venous blood

228

854

2.74

42.45

4.4

2.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

159

497

3.26

40.80

1.4

1.3

nmol/l

0.5

0.3

0.35

(3003338) MCHC [Mass/volume]

4065

35562

1.51

40.36

31.3

19.3

g/l

330.2

332.1

33.75

4036

35226

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

149

451

3.37

40.26

1.4

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

382

1855

2.14

39.89

1.7

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

704

4199

1.77

39.89

2.1

2.2

g/l

0.2

3.02

642

3895

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

382

1857

2.13

39.78

1.7

2.2

g/l

7.8

7.4

4.23

290

1360

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

1852

2.13

39.68

1.7

2.2

g/l

3.9

3.8

0.24

281

1296

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

709

4246

1.77

39.60

2.8

2.7

ng/l

283.8

218.8

2.38

662

3862

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

157

496

3.23

39.59

1.4

1.3

nmol/l

1.8

0.7

0.50

145

477

(3020891) Body temperature

408

2044

2.07

39.24

6.7

4.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4810

43811

1.66

39.01

6.3

4.8

mmol/l

6.6

6.0

92.81

4334

38884

(3007566) Smooth muscle Ab [Titer] in Serum

243

983

2.54

38.76

1.1

1.2

titre

208.7

130.1

0.39

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

359

1730

2.15

38.21

1.7

2.2

g/l

9.8

10.4

1.34

310

1421

(3013512) EKG study

1913

14612

1.47

37.68

6.1

3.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

286

1265

2.33

37.49

1.7

2.1

g/l

0.0

0.50

260

1133

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

1466

2.22

36.98

2.1

3.1

ratio

1.3

2.6

1.73

104

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

297

1349

2.27

36.57

1.7

2.1

g/l

0.0

0.1

1.76

271

1214

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

310

1434

2.23

36.53

1.7

2.0

g/l

36.7

37.4

1.15

269

1197

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

1735

2.12

36.41

1.7

2.2

g/l

3.2

3.1

1.73

287

1326

(3034860) Kappa light chains.free [Mass/volume] in Serum

322

1515

2.19

36.39

2.2

3.1

mg/l

59.3

59.4

0.01

271

1218

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

279

1243

2.31

35.96

1.7

2.1

g/l

0.0

0.00

259

1129

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

329

1569

2.16

35.93

1.9

2.2

g/l

0.6

1.2

1.89

284

1320

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

320

1512

2.18

35.78

2.3

3.1

mg/l

42.6

46.1

0.23

268

1221

(3028026) IgM [Mass/volume] in Serum or Plasma

425

2254

1.96

34.76

1.7

1.8

g/l

1.1

1.5

5.42

385

2016

(3042733) HLA Ab [Presence] in Serum

6.49

34.46

5.9

4.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

231

971

2.44

33.95

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

231

971

2.44

33.95

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

143

470

3.10

33.78

1.5

1.2

mmol/l

56.0

65.5

2.28

119

364

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

262

1168

2.30

33.71

1.4

iu/ml

38.3

20.3

—

(3036489) Thrombin time

301

1431

2.17

33.12

2.4

1.9

21.9

21.7

0.27

281

1254

(3044889) 12 lead EKG panel

3721

32535

1.42

32.57

5.2

4.0

—

(3010813) Leukocytes [#/volume] in Blood

5209

48927

1.84

32.42

35.7

21.6

e9/l

7.3

6.8

26.86

5031

47175

(3007461) Platelets [#/volume] in Blood

5207

48904

1.84

32.39

35.6

21.6

e9/l

238.9

241.4

1.78

5046

47360

(3024731) MCV [Entitic volume]

5207

48915

1.83

32.21

35.6

21.5

91.6

0.00

5137

47957

(3035941) MCH [Entitic mass]

5207

48916

1.83

32.19

35.5

21.5

30.3

30.5

9.49

5136

47959

(3009445) Proteinase 3 Ab [Units/volume] in Serum

362

1864

2.01

32.18

1.4

1.6

u/ml

18.5

20.4

—

(3026361) Erythrocytes [#/volume] in Blood

5207

48921

1.83

32.11

35.7

21.6

e12/l

4.4

4.5

16.51

5033

47194

(3000963) Hemoglobin [Mass/volume] in Blood

5207

48928

1.83

32.00

36.0

21.7

g/l

131.9

135.3

41.56

5136

47983

(40761511) CBC panel - Blood by Automated count

4935

45708

1.63

31.95

22.4

14.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2630

21723

1.39

31.84

2.6

2.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

253

1140

2.28

31.74

2.9

mmol/l

24.5

25.1

1.48

222

974

(3019230) Fractional oxyhemoglobin in Venous blood

185

728

2.59

31.26

4.4

2.2

66.2

64.4

0.50

185

723

(3043409) Potassium [Moles/volume] in Arterial blood

309

1519

2.09

31.17

5.6

4.1

mmol/l

4.0

3.9

1.24

299

1452

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

120

373

3.27

31.13

1.2

1.3

nmol/l

1.5

1.4

0.34

106

329

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1253

9079

1.49

31.10

2.8

3.2

mmol/l

2.5

3.36

1066

7977

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

869

2.45

30.99

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1111

7862

1.51

30.91

1.3

1.2

u/ml

1.7

1.9

0.19

271

2027

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

370

1961

1.95

30.25

3.0

3.1

pmol/l

4.2

4.4

2.65

328

1702

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1407

10490

1.45

30.01

1.8

1.7

pmol/l

31699195.3

30192894.5

0.03

1142

8469

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

233

1040

2.29

29.90

2.8

2.4

215.9

202.6

1.28

219

982

(3021879) Hepatitis B virus core Ab [Presence] in Serum

408

2245

1.88

29.78

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

338

1753

1.99

29.41

5.3

3.9

mmol/l

1.5

1.4

1.43

329

1737

(3038515) Glucose [Moles/volume] in Venous blood

224

996

2.30

29.00

4.5

3.0

mmol/l

7.6

7.7

0.07

219

975

(46235355) HIV 1 and 2 tests - Meaningful Use set

678

4349

1.64

28.81

1.9

1.5

—

(3036603) Volume of Urine

243

3.71

28.21

1.5

1.8

1782.4

1876.2

0.21

(3005719) IgG [Mass/volume] in Serum or Plasma

494

2932

1.75

28.05

2.8

2.7

g/l

10.5

10.6

0.17

457

2666

(3011985) Renin [Units/volume] in Plasma

127

438

2.94

27.64

1.9

1.4

mu/l

78.5

48.2

0.75

118

389

(40768797) Stomach Pathology biopsy report

881

6075

1.53

27.33

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

228

1049

2.22

27.22

4.5

2.9

mmol/l

1.6

1.7

0.09

223

1022

(3023183) Ammonium ion [Moles/volume] in Plasma

193

827

2.38

27.21

3.1

2.5

umol/l

34.4

35.0

0.12

157

684

(40761535) Cells panel - Urine sediment

663

4289

1.62

27.13

4.1

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

217

986

2.25

26.70

2.6

2.8

kpa

8.3

8.0

1.89

203

906

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

122

420

2.95

26.65

1.5

1.3

pmol/l

278.2

253.2

0.43

328

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

238

1134

2.15

26.04

2.7

2.1

89.0

88.6

0.09

232

1076

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

361

1994

1.87

25.99

1.9

ug/l

2.4

2.6

0.12

309

1738

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

263

1303

2.07

25.97

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

239

1148

2.13

25.61

3.4

2.4

g/l

3.8

3.6

0.84

229

1087

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

145

564

2.61

25.14

1.1

iu/ml

124.0

85.6

0.30

124

(3033705) Calcium.ionized [Moles/volume] in Venous blood

149

591

2.56

24.83

3.0

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

277

1447

1.96

23.60

1.4

1.6

titre

167.5

212.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

230

1129

2.08

23.30

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

217

1043

2.12

23.23

1.5

g/l

0.3

0.2

3.06

206

990

(40768446) Kidney Pathology biopsy report

114

4.68

23.07

1.5

—

(3011648) Oxygen content in Venous blood

294

3.16

22.90

1.9

1.6

10.9

11.2

0.23

294

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

240

3.41

22.77

2.4

2.2

ug/min

183.4

73.4

0.62

(3019060) Gas panel - Arterial blood

514

3259

1.64

22.65

4.7

4.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

220

1081

2.08

22.23

1.5

g/l

1.2

1.62

209

1026

(3004451) EKG impression Narrative

206

3.58

22.11

1.4

1.2

—

(3021901) Oxygen saturation in Capillary blood

183

839

2.22

22.08

2.4

2.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

118

444

2.69

21.90

1.5

1.3

nmol/l

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

198

3.62

21.89

1.3

nmol/l

1.2

0.17

152

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

408

2476

1.70

21.26

12.3

9.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

237

3.32

21.10

1.3

1.2

u/l

92.3

93.3

0.03

198

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

150

647

2.35

20.91

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

228

3.32

20.29

1.3

1.2

u/l

32.6

25.3

0.41

186

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

17.05

20.28

7.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

588

3957

1.54

20.03

1.7

1.6

1.5

1.37

476

3368

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

112

431

2.63

19.92

1.2

u/l

46.2

62.9

2.88

275

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

141

606

2.36

19.83

1.7

1.3

u/ml

95.6

121.9

1.97

145

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

323

1883

1.76

19.43

2.0

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

152

683

2.26

19.29

1.6

1.3

—

(3000330) Specific gravity of Urine by Test strip

391

2408

1.67

19.26

4.4

3.5

—

(3016038) Potassium [Moles/volume] in Urine

154

3.79

19.24

1.3

1.1

mmol/l

28.5

38.1

2.86

128

(3030981) Hyaline casts [#/volume] in Urine by Automated count

396

2449

1.66

19.19

3.4

2.6

e6/l

0.3

0.24

387

2406

(3027456) Digoxin [Moles/volume] in Serum or Plasma

214

1101

1.98

19.08

3.3

3.1

nmol/l

0.8

1.10

177

830

(3009542) Hematocrit [Volume Fraction] of Blood

4189

38570

1.33

18.99

26.8

15.8

37.9

39.4

12.39

2823

24741

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

591

2.33

18.68

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

238

1288

1.89

18.27

1.5

1.4

ug/g

250.4

267.3

0.62

141

777

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

343

2069

1.70

18.26

2.2

1.9

—

(3037121) Protein [Mass/volume] in Urine

275

1558

1.80

18.24

4.6

2.7

g/l

0.4

0.3

2.09

151

614

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.95

18.21

11.3

9.6

mmol/l

4.7

5.7

1.58

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

283

1634

1.77

17.61

2.0

1.7

u/l

37.5

39.0

0.56

220

1414

(4146454)

118

497

2.40

17.41

3.3

2.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

129

3.90

17.29

2.0

1.6

nmol/l

8.3

7.1

0.08

108

(3024932) HLA-DR beta [Type]

4.40

17.04

1.0

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

459

3028

1.56

17.02

8.3

6.9

mmol/l

24.2

24.6

1.48

431

2815

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

830

6190

1.40

16.48

1.3

1.2

u/ml

13.0

13.9

0.13

307

2261

(3024471) HLA-A [Type]

4.27

16.39

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

183

946

1.97

16.14

1.1

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

135

624

2.19

16.06

6.7

mg/l

11.9

11.7

0.24

121

570

(3019150) Specific gravity of Urine by Refractometry

1226

9769

1.33

15.85

4.9

4.3

kg/l

1.0

5.67

195

1426

(1761482) Bacteria [#/volume] in Urine by Culture

232

1308

1.81

15.67

4.9

4.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

107

454

2.38

15.58

4.2

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

123

556

2.24

15.47

1.3

1.2

u/ml

267.5

285.5

0.36

338

(3002385) Erythrocyte distribution width [Ratio]

3839

35283

1.28

15.45

29.2

17.7

14.1

13.8

26.32

3776

34365

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1435

11745

1.30

15.14

1.8

1.6

mmol/l

1.6

1.3

15.39

1213

9518

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

255

2.85

15.11

1.0

mg/l

294.0

287.5

0.29

226

(40760888) Immunoglobulin light chains.free panel - Serum

207

1140

1.85

15.09

2.4

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

157

3.40

15.02

2.0

2.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

177

928

1.94

15.01

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

863

6591

1.37

14.69

1.3

iu/ml

42.5

40.2

0.11

244

2021

(21494890) Protein electrophoresis panel - 24 hour Urine

106

468

2.29

14.13

1.7

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

600

4339

1.43

14.09

2.2

ug/g

159.1

155.2

0.08

488

3329

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

538

3814

1.45

14.06

3.1

2.5

ml/min/173m2

57.8

64.1

3.56

268

1487

(3004775) Volume in Urine collected for unspecified duration

385

2.41

13.85

2.5

2.1

701.3

643.9

0.62

236

(36660697) Celiac disease serology panel - Serum

411

2768

1.52

13.85

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

127

613

2.10

13.59

1.3

1.2

—

(3025315) Body weight

7.16

13.54

5.1

5.0

—

(3019225) pH of Specimen

684

5112

1.38

13.24

7.6

3.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

235

2.79

13.18

1.2

mmol/l

12.7

12.0

0.32

(44816559) Phosphatidylethanol [Mass/volume] in Blood

122

590

2.09

13.01

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

254

2.70

12.96

2.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

387

2611

1.52

12.93

2.5

2.4

—

(3037756) Immunofixation for Serum or Plasma

186

1041

1.81

12.92

1.5

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

443

2.26

12.83

2.2

1.4

—

(3016750) Collection duration of Urine

262

2.65

12.75

2.3

2.0

min

508.7

482.7

1.33

184

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

184

1045

1.79

12.20

2.0

1.8

mg/l

13.4

11.5

1.61

170

968

(3015171) Extractable nuclear Ab [Units/volume] in Serum

234

1422

1.67

12.18

1.2

u/ml

0.3

0.8

1.14

123

(3044927) Protein electrophoresis panel - Urine

105

496

2.14

11.93

1.4

1.1

—

(3000494) Fungus identified in Specimen by Culture

678

5148

1.36

11.84

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

181

1035

1.77

11.74

3.7

2.7

mg/l

2.0

1.6

6.91

165

932

(1616796) Gas panel - Central venous blood

175

991

1.79

11.73

4.9

3.6

—

(3021788) Differential panel - Synovial fluid

159

877

1.84

11.62

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

665

5067

1.35

11.33

4.3

3.3

—

(3032057) Clostridioides difficile [Presence] in Stool

110

3.47

11.23

1.9

1.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

229

1417

1.64

11.14

1.1

u/ml

42.5

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

281

2.47

11.10

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

105

514

2.06

10.91

24.2

17.9

mmol/l

8.1

7.2

1.47

418

(3029634) Reagin Ab [Titer] in Serum by VDRL

428

2.17

10.91

2.4

1.8

—

2.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

222

1376

1.64

10.74

2.0

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

281

2.44

10.62

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

188

2.78

10.61

1.2

1.1

iu/ml

2.8

3.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

599

1.96

10.41

3.8

2.4

u/ml

503.8

1531.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

296

2.38

10.41

1.2

titre

121.3

142.4

—

(3025941) Bacteria identified in Stool by Culture

312

2108

1.51

10.39

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

146

814

1.81

10.35

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

100

492

2.05

10.28

3.1

3.7

—

(40768804) Tissue Pathology biopsy report

2065

18241

1.21

10.10

2.4

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

288

2.38

10.08

2.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

143

799

1.81

10.08

7.1

4.4

iu/ml

325.2

2530.9

0.56

110

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1925

16900

1.21

10.02

5.1

4.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

169

2.80

9.72

2.9

3.9

mg/l

58.8

71.1

0.52

115

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

607

1.91

9.70

1.4

1.6

g/l

0.8

0.9

0.54

452

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.38

9.43

1.3

1.4

pmol/l

15.3

15.9

0.24

(3021387) Prolactin [Units/volume] in Serum or Plasma

119

643

1.87

9.36

2.5

1.7

mu/l

285.9

298.4

0.20

113

598

(3006184) Hemoglobin [Mass/volume] in Capillary blood

172

1038

1.68

9.28

2.2

2.1

g/l

129.9

129.0

0.17

114

734

(3036525) Urea [Moles/time] in 24 hour Urine

7.66

9.27

2.3

3.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.64

9.25

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.54

9.20

1.1

1.3

pmol/l

277.1

285.7

0.05

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

216

2.51

9.09

1.6

1.4

u/l

9.9

5.7

0.71

174

(3000492) Spirometry study

494

3725

1.36

8.97

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

111

595

1.88

8.97

1.5

e6/l

31612.6

56285.9

0.74

354

(3003434) Protein [Mass/volume] in Pleural fluid

129

727

1.79

8.89

1.5

1.4

g/l

30.9

32.3

0.54

117

652

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

102

535

1.92

8.81

3.8

3.2

nmol/l

6.7

17.4

0.52

522

(3023199) Leukocytes [#/volume] in Pleural fluid

117

647

1.83

8.59

1.5

e6/l

1388.0

2125.3

1.07

470

(40767503) Oxygen content in Capillary blood by calculation

163

992

1.66

8.55

2.8

2.2

16.5

16.2

0.52

503

(3044941) Cell count panel - Synovial fluid

128

730

1.77

8.49

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

472

1.96

8.49

4.2

2.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

200

2.51

8.44

2.3

1.8

nmol/l

15.9

16.0

0.04

187

(3049717) Cytology report of Urine Cyto stain

313

2209

1.44

8.40

2.6

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

187

1184

1.60

8.38

1.6

1.5

e6/l

14108.3

16282.5

0.21

131

864

(3012501) Base excess in Blood by calculation

170

1052

1.64

8.36

5.7

3.9

mmol/l

2.7

2.6

0.17

123

712

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

208

1351

1.56

8.36

1.5

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.46

8.35

6.1

4.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

155

2.72

8.32

35.0

25.1

ug/l

119.6

111.5

0.23

133

(3000093) Morphology [Interpretation] in Blood Narrative

441

1.99

8.32

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

179

1124

1.61

8.30

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1068

8988

1.23

8.20

4.8

4.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

203

2.48

8.20

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

3.39

8.06

1.1

1.3

mu/l

82.0

44.7

0.61

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.31

8.05

1.1

1.0

—

(3002256) Pathology report gross observation

760

6171

1.27

8.02

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

177

2.55

7.89

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

520

1.88

7.89

1.1

g/l

1.6

1.5

0.30

466

(3009214) Lutropin [Units/volume] in Serum or Plasma

127

739

1.74

7.89

1.5

1.3

u/l

10.2

10.1

0.01

101

602

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

133

785

1.71

7.85

1.9

1.6

iu/l

3.2

4.2

0.91

238

(4094501)

185

1193

1.57

7.70

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

665

5344

1.28

7.62

3.3

4.2

ug/l

8.4

24.5

4.21

555

4429

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

795

1.69

7.51

1.2

1.3

u/l

26.0

43.0

1.41

125

685

(3012565) Volume of 24 hour Urine

188

2.46

7.47

2.1

2.3

1912.7

1855.8

0.10

158

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

177

2.50

7.39

2.2

2.4

u/ml

1653.5

1463.0

0.10

177

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

220

2.33

7.36

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

220

2.33

7.36

1.2

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

183

1190

1.56

7.36

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

247

2.24

7.24

1.8

1.6

—

(3012441) Differential panel - Pleural fluid

100

559

1.80

7.16

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

258

1813

1.44

7.13

2.3

2.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

182

1194

1.54

7.05

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

512

1.83

7.01

1.2

u/ml

6.5

4.0

0.49

230

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

112

653

1.73

6.96

2.1

mg/l

25.6

26.0

0.02

163

(3014148) Varicella zoster virus Ab [Titer] in Serum

293

2.09

6.82

1.1

—

(3022145) Colonoscopy Study observation

623

5034

1.27

6.82

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

150

950

1.59

6.79

1.3

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

16.70

6.74

7.2

5.2

mmol/l

15.6

17.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

16.70

6.74

7.2

5.2

umol/l

406.4

420.3

—

(3010421) pH of Blood

186

1240

1.52

6.71

5.7

3.7

7.4

0.62

168

1029

(40768441) Liver Pathology biopsy report

282

2.10

6.69

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

104

601

1.74

6.68

1.0

1.1

—

(44806420)

156

2.51

6.66

2.5

2.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

506

1.81

6.66

1.2

1.3

u/l

431.8

340.8

0.52

477

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

179

1186

1.53

6.65

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

247

1746

1.43

6.64

2.6

3.5

u/ml

724.4

1534.3

0.49

212

1499

(3023410) Appearance of Cerebral spinal fluid

317

2.03

6.61

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

292

2128

1.39

6.60

1.3

u/ml

355.8

278.6

0.29

269

1940

(4306422)

493

1.82

6.60

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

366

1.95

6.56

1.1

1.2

96.2

94.2

0.22

345

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

114

680

1.69

6.55

1.1

1.2

u/ml

39.4

45.7

0.12

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

524

1.79

6.52

1.2

u/ml

4.2

4.4

0.04

177

(4035726)

524

4169

1.28

6.50

1.4

—

(3051651) Icteric interference index of Serum or Plasma

246

2.17

6.48

4.5

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

283

2059

1.39

6.47

1.2

iu/ml

144.6

132.5

0.15

718

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

2627

0.67

6.42

2.2

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

178

2.37

6.36

1.1

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

573

1.74

6.35

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

2.65

6.30

1.7

2.4

umol/l

97.5

125.8

0.28

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

269

2.09

6.29

2.0

1.1

—

(40768806) Pleura Pathology biopsy report

568

1.74

6.26

1.5

1.6

—

(3045788) Cell count panel - Pleural fluid

496

1.79

6.19

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

326

1.97

6.14

1.5

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

259

2.10

6.10

1.7

1.5

u/l

5.5

6.7

0.19

114

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

154

1008

1.54

6.09

1.1

1.2

u/ml

12.3

39.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

530

1.75

6.02

3.2

4.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

135

2.53

5.93

1.7

e6/l

14404.8

23920.9

0.24

(3029937) Albumin [Presence] in Urine by Test strip

1398

12389

1.17

5.89

5.0

4.1

estimate

0.0

1.47

349

3969

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

573

1.70

5.82

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

197

1374

1.45

5.74

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

138

2.47

5.68

3.0

2.8

umol/l

28.7

29.1

0.09

108

(3025468) Yersinia sp identified in Specimen by Organism specific culture

578

1.69

5.65

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

578

1.69

5.65

1.3

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

144

946

1.54

5.63

1.2

1.3

mg/l

604.7

547.5

0.55

139

899

(3025130) Human papilloma virus identified in Specimen

261

2.04

5.62

1.5

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

504

1.74

5.61

1.1

—

(4062490)

387

1.85

5.60

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

580

1.68

5.58

1.3

1.4

—

(3035880) pH of Pleural fluid

284

1.98

5.48

1.2

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

166

2.30

5.42

1.3

1.2

g/l

42.8

40.4

0.57

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

525

1.71

5.40

1.1

—

(3006270) Folate [Moles/volume] in Blood

393

1.82

5.35

1.3

1.2

nmol/l

292.5

337.6

1.21

311

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

595

1.66

5.34

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

161

1098

1.48

5.29

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

402

1.80

5.28

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

402

1.80

5.28

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

402

1.80

5.28

1.5

1.6

—

(3033799) Differential panel - Peritoneal fluid

137

2.42

5.28

2.2

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

440

1.76

5.23

1.1

1.2

u/ml

42.1

50.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

478

1.73

5.20

1.1

126.6

112.6

2.53

426

(3051387) C reactive protein [Mass/volume] in Capillary blood

149

1005

1.50

5.18

5.1

3.5

mg/l

21.0

30.3

3.59

617

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

127

828

1.55

5.17

1.2

mmol/l

4.3

3.8

3.76

118

780

(3022621) pH of Urine by Test strip

383

3022

1.29

5.11

3.6

3.1

—

(3008295) Osmolality of Serum or Plasma

327

1.87

5.10

1.5

1.2

mosm/kgh2o

275.5

284.3

2.70

241

(3023487) Leukocytes [#/volume] in Peritoneal fluid

158

2.29

5.10

1.9

e6/l

353.0

3909.9

0.58

107

(3051593) INR in Capillary blood by Coagulation assay

264

1.98

5.10

16.7

13.2

—

(21494755) Public health laboratory ask at order entry panel

161

2302

0.69

5.09

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

307

1.90

5.05

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

343

1.85

5.03

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

479

3892

1.25

5.02

3.7

4.0

1.0

0.00

156

1124

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

168

1170

1.45

4.98

1.6

iu/ml

20.7

7.5

0.28

257

(3024522) Salmonella sp identified in Specimen by Organism specific culture

585

1.63

4.93

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

122

800

1.54

4.86

1.3

1.4

e6/l

754.0

834.7

0.06

666

(3028192) IgG subclass 2 [Mass/volume] in Serum

391

1.77

4.85

1.3

1.4

g/l

3.0

0.01

268

(3021440) Promyelocytes/100 leukocytes in Blood

456

3702

1.25

4.82

3.6

4.0

0.1

0.20

141

1041

(3016018) Differential panel - Cerebral spinal fluid

370

1.79

4.81

1.1

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

407

1.75

4.81

1.3

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

216

1588

1.37

4.73

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

121

799

1.53

4.69

1.2

1.4

e6/l

35.1

18.8

0.24

635

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

218

2.03

4.65

4.0

2.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

391

1.75

4.57

1.3

1.4

g/l

0.4

0.11

268

(3027135) IgG subclass 1 [Mass/volume] in Serum

391

1.75

4.57

1.3

1.4

g/l

6.4

6.8

0.39

267

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

14.01

4.57

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

105

676

1.56

4.57

5.1

2.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

139

952

1.47

4.53

1.1

1.2

u/ml

5.9

2.5

0.84

(3036782) Glucose [Moles/volume] in Pleural fluid

475

1.67

4.53

1.4

1.3

mmol/l

7.1

6.1

1.78

433

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

114

1697

0.67

4.50

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

140

962

1.47

4.49

1.1

1.2

u/ml

6.1

4.4

0.28

154

(3028707) Methadone [Presence] in Urine by Screen method

242

1.95

4.48

1.4

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

122

821

1.50

4.35

2.9

3.7

1.2

1.5

0.64

628

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.91

4.33

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.91

4.33

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.91

4.33

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

109

717

1.53

4.33

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

11.68

4.27

2.0

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

290

1.84

4.23

1.2

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.51

4.20

1.7

1.3

g/l

28.4

28.3

0.01

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

298

1.82

4.19

1.2

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.27

4.18

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

249

1.90

4.14

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

249

1.90

4.14

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

162

1163

1.40

4.13

1.6

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

528

1.60

4.08

2.5

3.8

62.4

58.1

0.97

334

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

258

1.87

4.06

2.7

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

230

1.92

4.04

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

121

827

1.47

4.03

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

223

1693

1.33

4.02

1.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

232

1.90

3.95

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

232

1.90

3.95

1.5

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

232

1.90

3.95

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

232

1.90

3.95

1.5

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

533

1.58

3.94

5.1

4.4

umol/l

336.1

349.5

0.41

444

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

154

1106

1.40

3.94

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.43

3.90

1.6

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

249

1.85

3.83

1.2

1.1

—

(4010399)

408

3362

1.23

3.82

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

756

6592

1.17

3.81

9.2

7.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1014

0.61

3.80

1.5

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.60

3.80

2.0

1.3

ng/l

192.1

132.9

0.59

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.43

3.79

3.0

3.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

229

1.88

3.76

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

229

1.88

3.76

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

174

2.02

3.73

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

115

2.27

3.70

1.5

—

(3016879) Cocaine [Presence] in Urine

495

1.58

3.68

1.3

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

802

1.46

3.68

1.1

1.2

u/ml

1.2

4.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

186

1395

1.34

3.67

1.9

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

189

1.96

3.66

1.2

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

100

674

1.49

3.61

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

262

1.80

3.58

1.4

u/l

18.6

30.9

2.31

217

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.79

3.55

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

2.02

3.53

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

716

6254

1.17

3.53

6.4

4.5

32.2

32.8

0.74

460

4038

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

124

876

1.42

3.52

1.4

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.16

3.50

6.8

2.0

—

(3045414) Leukocytes [Presence] in Urine

254

2008

1.28

3.44

2.0

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2257

21214

1.11

3.39

5.0

5.3

ug/l

2.5

3.7

3.54

1969

18926

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

867

1.42

3.37

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

341

2800

1.23

3.33

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

535

1.52

3.25

1.3

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

100

690

1.46

3.25

1.5

1.3

iu/l

30.6

32.1

0.17

590

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

649

1.47

3.25

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

394

1.61

3.21

1.1

u/ml

13.2

2.6

0.72

139

(3027035) Albumin [Mass/time] in 24 hour Urine

3.34

3.19

1.0

1.4

—

236.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

102

711

1.44

3.15

1.4

—

(1002224) Polysomnography panel

168

1273

1.33

3.15

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

298

2429

1.24

3.14

1.3

au/ml

62.3

61.3

—

109

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

222

1.81

3.14

1.1

u/l

92.5

94.8

0.06

168

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

222

1.81

3.14

1.1

u/l

35.2

32.6

0.09

166

(3028300) Cannabinoids [Presence] in Urine

540

1.51

3.13

1.3

2.0

—

(3027944) Amphetamines [Presence] in Urine

524

1.51

3.13

1.3

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

1.82

3.12

2.5

2.4

—

(21494434) Karyotype in Bone marrow

421

1.57

3.11

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

152

1144

1.34

3.00

2.0

1.7

mg/l

4.5

3.9

0.17

133

809

(3000764) Benzodiazepines [Presence] in Urine

530

1.50

2.98

1.3

2.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.00

2.97

1.1

2.4

mmol/l

0.9

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

303

1.66

2.91

2.5

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

2.09

2.88

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

144

1083

1.34

2.87

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

185

1.84

2.86

1.1

iu/ml

8.6

11.5

—

(40768800) Prostate Pathology biopsy report

106

1460

0.72

2.85

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

216

1.76

2.79

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

216

1.76

2.79

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

530

1.48

2.79

1.5

—

(3014891) Appearance of Pleural fluid

2.55

2.78

1.6

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

135

1012

1.34

2.76

2.5

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

622

1.44

2.76

1.6

1.9

—

(3045142) Bone marrow Pathology biopsy report

507

1.49

2.75

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

247

1.71

2.75

2.0

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

1.87

2.65

2.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

119

2.02

2.65

1.0

1.1

miu/ml

1511.2

1618.1

0.21

119

(3025159) Blasts/100 leukocytes in Blood

406

3472

1.18

2.65

3.6

4.0

0.8

0.3

0.32

114

878

(3044007) Cell count panel - Peritoneal fluid

126

1.99

2.65

2.0

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

140

1.93

2.64

2.0

1.7

ug/l

74.0

53.1

0.93

134

(3011288) Drugs identified in Urine by Screen method

340

1.56

2.50

1.6

2.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

445

1.49

2.49

1.0

1.1

u/ml

0.6

1.9

1.50

181

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

4.38

2.47

1.0

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.20

2.47

1.0

1.2

umol/24h

1.0

0.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

489

1.46

2.42

1.4

1.3

e6/l

129597.5

166271.1

0.19

340

(3042111) Morphology [Interpretation] in Bone marrow Narrative

110

821

1.35

2.37

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

412

3564

1.17

2.36

3.5

3.9

0.6

0.7

0.45

107

812

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.07

2.36

1.4

1.5

ug/l

0.4

0.08

(3019977) pH of Arterial blood

252

1.63

2.32

1.6

2.3

7.4

0.53

110

(3000034) Microalbumin [Mass/volume] in Urine

395

1.50

2.32

3.1

2.7

mg/l

23.0

34.5

0.54

283

(3022689) Creatine [Moles/volume] in Urine

2.04

2.31

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

192

1.72

2.29

1.5

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

192

1.72

2.29

1.5

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.02

2.25

1.0

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

358

1.51

2.24

1.2

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

273

1.58

2.16

1.2

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.29

2.15

2.5

1.9

mmol/l

4.5

4.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

149

0.33

2.14

1.2

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

462

1.43

2.11

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.91

2.07

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

407

1.45

2.04

1.5

—

(40768443) Skin Pathology biopsy report

255

2150

1.19

2.02

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

192

1.67

2.02

1.6

2.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.63

2.01

2.2

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.82

2.00

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

193

1.66

1.99

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

452

1.42

1.97

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

141

1.78

1.96

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

105

1.91

1.95

1.1

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.36

1.94

2.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

718

1.33

1.94

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

218

1.61

1.93

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

2.73

1.93

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

150

1206

1.25

1.91

1.9

1.7

nmol/l

39.3

44.2

1.72

142

1154

(3003694) ABO and Rh group [Type] in Blood

1213

11336

1.09

1.90

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

226

1898

1.20

1.89

4.1

5.1

1.4

1.6

3.11

221

1765

(4281824)

414

1.43

1.89

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

1.64

1.89

1.1

—

(3045424) Erythrocytes [Presence] in Urine

100

766

1.31

1.87

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.31

1.87

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

107

1.87

1.85

2.0

2.6

mmol/l

9.1

7.4

1.03

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

221

1.59

1.84

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.53

1.83

2.8

1.5

nmol/l

10.4

3.2

—

(3017704) Immunofixation for Urine

253

1.55

1.83

1.5

—

(4198724)

2.06

1.80

1.0

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.05

1.80

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.96

1.79

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

328

1.47

1.78

2.1

1.9

u/l

328.2

1208.2

0.92

117

(4268621)

353

1.45

1.78

2.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.92

1.72

1.4

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.92

1.72

6.4

7.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.13

1.71

1.2

mmol/l

5.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

211

1.57

1.67

1.1

—

(3017732) Neutrophils [#/volume] in Blood

339

2977

1.15

1.67

3.5

3.0

e9/l

4.6

4.2

1.59

221

2178

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

112

887

1.27

1.66

1.8

pmol/l

174.6

209.3

2.55

104

834

(3024263) Appearance of Synovial fluid

260

1.50

1.65

1.5

—

(4027681)

165

1.64

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

385

1.41

1.63

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

608

1.32

1.62

1.1

1.3

miu/ml

128.7

201.5

1.47

215

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.15

1.61

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.61

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

1.59

1.4

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1161

0.78

1.57

1.9

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

526

4767

1.11

1.57

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

571

1.32

1.52

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

476

1.35

1.52

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

141

0.42

1.51

1.7

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

241

1.50

1.51

1.1

mg/l

47.6

42.6

0.23

197

(3032868) Hemoglobin electrophoresis panel in Blood

2.59

1.51

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

417

3740

1.12

1.51

2.8

2.1

nmol/l

11.2

12.8

4.06

363

3291

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.86

1.50

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

316

1.43

1.50

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

256

0.55

1.48

1.4

1.6

—

(3045716) Anion gap in Serum or Plasma

216

0.51

1.46

2.6

2.5

mmol/l

9.2

9.1

—

165

(3020393) Adenovirus Ag [Presence] in Stool

2.37

1.45

1.1

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.12

1.44

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.12

1.44

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

228

1.49

1.43

1.1

mg/l

307.7

308.6

0.01

195

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

613

1.29

1.42

1.6

1.5

63.2

61.1

0.19

396

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

245

1.47

1.42

1.2

1.3

u/ml

0.1

1.2

1.34

126

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

448

1.34

1.41

1.6

1.7

—

(3020491) Glucose [Moles/volume] in Blood

305

1.41

1.37

1.6

1.9

mmol/l

8.0

6.8

1.72

204

(3038177) Helicobacter pylori Ab [Presence] in Serum

529

1.31

1.36

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

444

4025

1.11

1.35

5.2

3.3

mmol/l

1.2

2.18

385

3421

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.34

0.0

4.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

168

1.55

1.31

1.1

u/l

1.2

1.1

0.11

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

368

1.36

1.30

1.1

—

52.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.09

1.30

10.1

4.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

161

1.56

1.28

1.1

1.3

ug/l

30.9

557.3

1.38

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

319

1.38

1.26

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1059

0.80

1.26

1.9

1.7

—

(3006462) Nitrate [Presence] in Urine

227

1.46

1.26

3.5

3.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

219

1.46

1.25

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

115

1.65

1.24

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.40

1.24

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.40

1.24

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

179

1.51

1.23

1.1

1.8

umol/l

6.2

12.3

0.66

125

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

399

1.33

1.21

1.9

1.7

u/ml

16.6

28.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.63

1.21

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

180

1.50

1.20

1.1

ng/l

146.4

812.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

444

1.31

1.19

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.83

1.19

1.4

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

181

1.49

1.18

1.4

ug/l

5.9

7.6

1.07

159

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

165

1.52

1.17

2.0

1.8

u/ml

188503.7

19149.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.70

1.17

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

128

0.47

1.16

1.3

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

128

0.47

1.16

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

128

0.47

1.16

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

128

0.47

1.16

1.3

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

102

1.67

1.16

5.8

7.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

257

1.40

1.15

1.3

1.4

nmol/l

0.2

0.06

191

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

257

1.40

1.15

1.8

2.4

e6/l

372.5

573.0

1.02

120

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.50

1.15

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.15

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

107

887

1.21

1.14

1.1

u/ml

9.9

7.4

0.21

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.33

1.12

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.33

1.12

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

1.62

1.11

1.7

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

681

1.24

1.11

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

388

1.32

1.11

1.0

1.1

u/ml

1.7

4.1

1.45

190

(3009871) Measles virus Ab [Titer] in Serum

1.67

1.10

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.95

1.08

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

120

1.59

1.08

1.0

1.1

u/ml

0.2

0.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.19

1.08

1.3

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.87

1.07

1.3

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

1.49

1.06

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

374

1.31

1.05

1.0

1.1

u/ml

0.7

0.02

164

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

262

1.38

1.05

1.7

2.4

e6/l

529.0

508.2

0.08

221

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.79

1.04

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

377

4120

0.91

1.04

1.4

—

(3011412) CD3 cells [#/volume] in Blood

384

1.30

1.03

1.8

2.2

e9/l

1.2

1.1

0.26

231

(3047189) Immunofixation for 24 hour Urine

212

1.42

1.03

1.4

1.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.83

1.02

2.6

1.7

mmol/l

1.2

0.11

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.83

1.02

2.2

2.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

171

1.46

1.02

1.2

1.3

57.2

57.6

0.02

144

(3005033) Fetal Nuchal fold Thickness US

106

0.47

1.01

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

106

0.47

1.01

1.6

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1284

12298

1.06

1.00

3.0

3.2

ug/l

0.7

0.8

0.75

943

8700

(3043238) Trisomy 21 risk [Likelihood] in Fetus

109

0.46

1.00

1.4

1.6

—

(3034426) Prothrombin time (PT)

123

1.55

0.99

1.2

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1174

11221

1.06

0.99

4.6

3.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

206

1.41

0.98

1.1

1.4

57.8

65.6

0.52

167

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.17

0.98

1.6

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

135

0.52

0.98

1.4

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

388

1.29

0.97

1.1

—

3.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

362

1.30

0.97

1.0

ng/l

317.2

341.8

0.25

237

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

362

1.30

0.97

1.0

ng/l

735.5

725.8

0.06

228

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

635

0.79

0.94

1.4

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

364

1.29

0.94

1.0

ng/l

46.0

47.0

0.05

235

(3036071) Salmonella sp Ab [Titer] in Serum

1.61

0.93

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

1.59

0.93

1.1

1.2

96.9

82.3

—

(3028433) Virus identified in Specimen by Culture

158

1.46

0.93

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.63

0.90

1.4

1.1

—

(4211845)

244

1.35

0.90

3.5

3.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

555

1.23

0.89

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

119

1.51

0.88

1.0

1.3

nmol/l

159.9

140.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

111

1.53

0.87

1.4

1.3

110.1

111.2

0.05

(3020191) Ethanol [Moles/volume] in Serum or Plasma

272

1.33

0.87

1.2

1.3

promille

1.6

1.4

0.49

211

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.00

0.87

2.3

3.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

195

1.39

0.86

1.1

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

450

1.25

0.85

1.2

1.1

—

2.5

—

(40757373) Influenza virus identified in Isolate

1.63

0.84

1.2

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.94

0.84

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

146

1.44

0.82

19.3

14.2

nmol/l

678.6

812.3

0.67

136

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.88

0.81

1.2

g/l

0.0

0.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.88

0.81

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.65

0.81

1.2

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.70

0.80

1.3

1.1

—

(44813793)

241

1.33

0.80

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

233

1.33

0.79

1.1

nmol/l

3.9

13.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

411

1.24

0.78

2.3

2.1

u/field

3.8

1.6

0.91

123

(40765089) Chromosome analysis panel - Blood by G-banded

1.77

0.76

1.2

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

458

1.22

0.75

1.1

—

9.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.54

0.75

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.57

0.74

1.8

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.80

0.72

1.0

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.92

0.70

1.4

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

1.43

0.70

1.3

1.2

—

(3048879) Bone marrow aspiration report

160

1.38

0.70

1.2

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

1.49

0.70

1.1

87.5

81.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

101

1.49

0.70

2.6

—

(3047181) Lactate [Moles/volume] in Blood

121

1368

0.88

0.69

3.9

6.2

mmol/l

1.6

1.3

1.24

108

1203

(3019174) dRVVT (LA screen)

1.85

0.68

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.68

1.3

1.9

umol/l

49.9

46.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

277

1.27

0.65

1.5

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

839

0.86

0.64

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.47

0.64

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

125

1113

1.13

0.63

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

1.34

0.63

8.1

6.3

—

(4015189)

155

1.36

0.62

1.8

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

138

1.38

0.62

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

740

1.15

0.61

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.57

0.60

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.57

0.60

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.50

0.59

1.2

1.7

—

(3017569) Oxygen content in Arterial blood

236

1.27

0.59

1.7

2.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

254

1.26

0.59

1.7

2.5

e9/l

0.3

0.2

0.20

222

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

183

1.31

0.59

1.5

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

836

1.14

0.59

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

161

1466

1.10

0.57

1.4

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.57

0.56

1.8

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

476

1.18

0.55

1.4

31.5

29.2

0.18

297

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.56

0.55

1.2

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

504

1.17

0.55

1.3

—

(3008898) HLA-B27 [Presence]

106

945

1.12

0.55

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

306

0.78

0.54

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

143

1.33

0.52

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.50

0.51

1.0

1.3

umol/24h

2.7

2.0

—

(3023419) Bacteria identified in Sputum by Culture

639

1.14

0.51

2.7

2.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.41

0.51

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

333

1.20

0.51

1.1

u/ml

1.5

1.6

0.05

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

500

1.16

0.50

1.7

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

177

1632

1.09

0.50

1.5

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.49

0.49

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

107

0.65

0.48

1.0

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

636

0.86

0.48

3.2

3.8

u/ml

18.0

49.3

3.60

616

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.46

0.46

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

182

1.26

0.46

1.3

1.4

—

(3001729) Color of Synovial fluid

1.40

0.45

1.3

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.34

0.44

1.7

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.34

0.44

1.7

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.43

1.2

1.1

u/l

57.8

10.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.43

0.42

1.4

1.3

85.4

72.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.65

0.42

1.0

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

140

1.29

0.41

1.9

2.2

umol/l

71.2

57.9

0.81

110

(3042631) Mycobacterium sp identified in Specimen

756

1.11

0.41

2.4

2.8

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1316

13451

0.97

0.40

4.6

3.0

—

(3000285) Sodium [Moles/volume] in Blood

1.39

0.40

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

895

1.10

0.38

3.7

60.8

57.9

1.30

895

(44790048)

478

1.13

0.36

1.5

1.4

—

(44790049)

478

1.13

0.36

1.5

1.4

—

(44806118)

478

1.13

0.36

1.5

1.4

—

(44790047)

478

1.13

0.36

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1.16

0.36

1.4

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.40

0.35

2.2

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.40

0.35

2.5

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

190

1.21

0.34

1.2

—

(4212803)

1.33

0.33

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

193

2043

0.94

0.33

1.3

—

(40768793) Breast Pathology biopsy report

832

0.91

0.32

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

174

1.21

0.31

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

295

1.15

0.31

1.4

2.0

14.4

14.7

0.03

120

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

267

1.16

0.31

3.0

4.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

239

1.17

0.31

1.8

1.7

u/field

2.7

2.2

0.19

151

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.35

0.31

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

296

1.15

0.30

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

296

1.15

0.30

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

111

1.26

0.30

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

111

1.26

0.30

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

111

1.26

0.30

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

111

1.26

0.30

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

111

0.72

0.28

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

227

0.84

0.28

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.32

0.28

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.28

0.28

1.1

—

(40768795) Lymph node Pathology biopsy report

449

0.89

0.27

1.4

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

427

4137

1.03

0.27

1.7

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.25

0.27

1.4

1.2

—

78.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.74

0.27

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

215

0.84

0.27

1.9

2.9

32.4

37.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.21

0.26

1.3

1.2

—

78.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.26

0.26

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

179

1704

1.05

0.26

3.5

4.0

u/ml

56.7

88.2

1.13

173

1640

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

120

1131

1.06

0.25

2.6

3.3

u/ml

303.3

785.8

0.92

104

1036

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1729

17081

1.02

0.24

4.0

4.6

22.9

21.8

2.07

854

9159

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.26

0.24

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

1.21

0.24

2.5

2.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.32

0.23

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

669

1.08

0.23

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.28

0.23

1.4

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

134

1.19

0.22

1.3

2.2

12.1

11.6

0.03

118

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

134

1.19

0.22

1.1

2.1

24.3

29.8

0.66

122

(3005011) Chlamydia sp Ab [Titer] in Serum

1.19

0.21

2.2

1.7

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1470.9

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.16

0.21

22.0

8.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.16

0.21

4.2

2.1

u/field

1.0

0.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

412

1.09

0.20

1.3

1.2

mmol/l

8.5

7.8

0.62

293

(3020650) Glucose [Presence] in Urine

123

0.81

0.20

1.1

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

123

0.81

0.20

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.20

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

217

0.88

0.18

1.7

2.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.13

0.17

1.4

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

291

1.10

0.17

1.0

u/ml

4.6

2.1

0.34

111

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.11

0.17

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

330

0.91

0.17

1.8

1.4

pmol/l

32.1

169.6

0.68

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.72

0.16

6.2

7.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

417

1.08

0.16

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.18

0.16

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

402

0.92

0.16

2.2

1.9

ug/l

3.7

3.1

0.25

352

(3025577) Chromium [Mass/volume] in Blood

391

0.92

0.16

2.3

2.0

ug/l

2.7

2.0

0.60

328

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

187

1.12

0.15

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

178

1.12

0.15

1.4

1.2

—

(3000012) Reticulocyte production index

286

0.91

0.15

1.4

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.08

0.14

5.0

7.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

171

0.88

0.14

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

112

1.16

0.14

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

118

0.85

0.14

1.5

1.2

—

(4133840)

113

1.15

0.13

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

117

0.85

0.13

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

307

1.08

0.12

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

415

1.06

0.11

1.3

—

(40761536) Microorganisms panel - Urine sediment

387

3933

0.98

0.11

5.3

3.8

—

(40765096) Chromosome analysis panel by Banding

172

1.11

0.11

1.5

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

0.88

0.11

1.0

1.5

iu/ml

—

1687425.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

115

1.13

0.10

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.15

0.10

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.11

0.09

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

166

0.90

0.09

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.09

0.09

1.0

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.09

0.09

1.4

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.09

0.09

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.09

0.09

1.0

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.15

0.09

7.1

5.6

u/l

40.8

39.8

—

(4024509)

492

0.95

0.09

1.9

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.07

0.08

3.7

3.9

umol/l

25.0

42.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.08

0.08

1.1

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.03

0.07

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

166

1.08

0.07

1.6

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

372

1.05

0.07

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.80

0.07

1.0

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

194

0.93

0.07

1.1

ratio

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.84

0.07

2.0

3.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

198

1.06

0.05

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

414

0.97

0.05

2.0

3.7

u/ml

21.6

42.7

2.66

407

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

0.92

0.04

1.1

—

(3015183) Erythrocyte sedimentation rate

129

0.93

0.03

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

260

1.04

0.03

8.1

4.7

u/ml

18.3

91.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

419

1.03

0.03

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

138

0.94

0.02

1.5

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

148

0.95

0.02

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1.05

0.02

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

242

1.03

0.02

1.5

3.2

4.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

106

0.94

0.01

1.9

1.6

ug/l

9.6

9.1

—

106

(3023430) Cat dander IgE Ab [Units/volume] in Serum

265

1.02

0.00

1.0

1.1

u/ml

1.1

3.0

1.18

100

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

114

0.96

0.00

1.1

—

(40762814) Titanium [Mass/volume] in Blood

107

1.03

0.00

2.3

2.2

ug/l

3.5

3.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

101

0.99

0.00

5.2

8.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.00

0.00

1.0

1.3

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.1

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

171.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.98

0.00

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.87

0.00

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

3001.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

50.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.95

0.00

1.4

1.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.95

0.00

1.4

1.2

mg/l

0.5

74.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.96

0.00

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.01

0.00

1.1

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.93

0.00

1.0

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.7

—

141.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_LIPOPROTNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_LIPOPROTNAS	1.356 [1.24, 1.48]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.346

During the follow-up period (1.1.1998 — 31.12.2019), 4301 out of 14342 females with E4_LIPOPROTNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_LIPOPROTNAS	1.389 [1.26, 1.53]	< 0.001
Birth year	0.983 [0.97, 0.99]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 4907 out of 17226 males with E4_LIPOPROTNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_LIPOPROTNAS.

N-year risk	Females	Males
1	0.161%	0.244%
5	0.905%	1.453%
10	2.244%	3.514%
15	4.322%	6.696%
20	7.342%	11.126%

Relationships between endpoints

↥

Index endpoint: E4_LIPOPROTNAS – Disorder of lipoprotein metabolism, unspecified

GWS hits: 11

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorder of lipoprotein metabolism, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints